Document:

Exhibit 10.1

Exhibit 10.1

Execution Version

SECURITIES PURCHASE AGREEMENT

By and Among

MORGANS HOTEL GROUP CO.

and

YUCAIPA AMERICAN ALLIANCE FUND II, L.P.,

and

YUCAIPA AMERICAN ALLIANCE (PARALLEL) FUND II, L.P.,

Dated as of October 15, 2009

 

 

TABLE OF CONTENTS

	 	 	 	 	 
	 	 	Page	 
	 
	 	 	 	 
	ARTICLE 1 DEFINED TEMS
	 	 	1	 
	 
	 	 	 	 
	ARTICLE 2 ISSUANCE AND SALE OF INVESTOR SECURITIES
	 	 	10	 
	2.1 Issuance and Sale of the Investor Securities
	 	 	10	 
	2.2 Deliveries
	 	 	10	 
	2.3 Allocation of Investment Amount
	 	 	11	 
	 
	 	 	 	 
	ARTICLE 3 REPRESENTATIONS AND WARRANTIES OF THE COMPANY
	 	 	12	 
	3.1 Entity Status
	 	 	12	 
	3.2 Authorization; Noncontravention
	 	 	12	 
	3.3 Capital Structure
	 	 	14	 
	3.4 Real Property
	 	 	16	 
	3.5 Intellectual Property
	 	 	17	 
	3.6 Environmental Matters
	 	 	17	 
	3.7 Legal Proceedings
	 	 	18	 
	3.8 Taxes
	 	 	18	 
	3.9 Labor
	 	 	19	 
	3.10 Employee Benefit Plans
	 	 	19	 
	3.11 Compliance with Laws
	 	 	20	 
	3.12 SEC Reports and Company Financial Statements
	 	 	20	 
	3.13 Material Contracts
	 	 	22	 
	3.14 Absence of Certain Changes
	 	 	23	 
	3.15 Insurance
	 	 	24	 
	3.16 Private Placement
	 	 	24	 
	3.17 Form S-3 Eligibility
	 	 	25	 
	3.18 Brokers
	 	 	25	 
	3.19 Listing and Maintenance Requirements
	 	 	25	 
	3.20 Registration Rights
	 	 	25	 
	3.21 No Restriction on the Ability to Pay Cash Dividends
	 	 	25	 
	3.22 Joint Ventures
	 	 	25	 
	 
	 	 	 	 
	ARTICLE 4 REPRESENTATIONS AND WARRANTIES OF THE INVESTORS
	 	 	26	 

 

-i-

 

TABLE OF CONTENTS
(continued)

	 	 	 	 	 
	 	 	Page	 
	 
	 	 	 	 
	4.1 Entity Status
	 	 	26	 
	4.2 Authorization; Noncontravention
	 	 	26	 
	4.3 Securities Act; Purchase for Investment Purposes
	 	 	27	 
	4.4 Brokers
	 	 	28	 
	4.5 Available Funds
	 	 	28	 
	 
	 	 	 	 
	ARTICLE 5 COVENANTS
	 	 	28	 
	5.1 Further Assurances
	 	 	28	 
	5.2 Fees and Expenses; Commitment Fee
	 	 	29	 
	5.3 Stockholder Approvals
	 	 	29	 
	5.4 Rights Plan
	 	 	29	 
	5.5 Gaming and Liquor Licenses
	 	 	30	 
	5.6 Certain Approval Rights
	 	 	30	 
	5.7 Board Representation
	 	 	31	 
	5.8 Publicity
	 	 	34	 
	5.9 Hedging
	 	 	34	 
	5.10 Investor Right of First Refusal
	 	 	34	 
	5.11 VCOC
	 	 	35	 
	5.12 Certain Tax Matters
	 	 	35	 
	5.13 Standstill Agreement
	 	 	36	 
	5.14 Company Right of First Refusal
	 	 	38	 
	 
	 	 	 	 
	ARTICLE 6 INDEMNIFICATION
	 	 	39	 
	6.1 Indemnification
	 	 	39	 
	 
	 	 	 	 
	ARTICLE 7 GENERAL PROVISIONS
	 	 	41	 
	7.1 Amendments and Waivers
	 	 	41	 
	7.2 Assignment
	 	 	41	 
	7.3 No Third-Party Beneficiaries
	 	 	41	 
	7.4 Notices
	 	 	42	 
	7.5 Counterparts
	 	 	42	 
	7.6 Entire Agreement
	 	 	43	 
	7.7 Interpretation; Exhibits and Schedules
	 	 	43	 

 

-ii-

 

TABLE OF CONTENTS
(continued)

	 	 	 	 	 
	 	 	Page	 
	 
	 	 	 	 
	7.8 Severability
	 	 	43	 
	7.9 Consent to Jurisdiction
	 	 	43	 
	7.10 Governing Law
	 	 	43	 
	7.11 Waiver of Jury Trial
	 	 	43	 
	7.12 No Personal Liability of Partners, Directors, Officers, Owners, Etc
	 	 	44	 
	7.13 Rights of Holders
	 	 	44	 
	7.14 Adjustment in Share Numbers and Prices
	 	 	44	 
	7.15 Construction
	 	 	44	 

 

-iii-

 

TABLE OF CONTENTS
(continued)

	 	 	 
	 	 	Page

LIST OF EXHIBITS

	 
	Exhibit A Form of Certificate of Designations

	Exhibit B Form of Warrant

	Exhibit C Form of Real Estate Fund Formation Agreement

	Exhibit D Form of Registration Rights Agreement

	Exhibit E Form of Rights Plan Amendment

	Exhibit F Form of Secretary’s Certificate

	Exhibit G Form of Opinion of Sullivan & Cromwell LLP

	Exhibit H Form of Opinion of Munger, Tolles & Olson LLP

	Exhibit I Forms of Management Rights Letters

 

-iv-

 

SECURITIES PURCHASE AGREEMENT, dated as of October 15, 2009 (the “Agreement”), by and
among MORGANS HOTEL GROUP CO., a Delaware corporation (the “Company”), and YUCAIPA AMERICAN
ALLIANCE FUND II, L.P., a Delaware limited partnership (“YAAF II”), and YUCAIPA AMERICAN
ALLIANCE (PARALLEL) FUND II, L.P., a Delaware limited partnership (“YAAF II-P” and together
with YAAF II, the “Investors”).

A. WHEREAS, the Investors desire to purchase from the Company, and the Company desires to
issue and sell to the Investors, against payment of the Investment Amount and pursuant to the terms
and conditions set forth in this Agreement, (a) 75,000 shares of the Company’s preferred stock, par
value $0.01 per share, designated as Series A Preferred Securities (the “Preferred
Securities”), having the voting and other powers, preferences and relative, participating,
optional or other rights, and the qualifications, limitations and restrictions as specified in the
Certificate of Designations of the Series A Preferred Securities of the Company in the form
attached hereto as Exhibit A (the “Certificate of Designations”), and (b) warrants
in the form attached hereto as Exhibit B (the “Warrants” and, together with the
Preferred Securities, the “Investor Securities”) to acquire 12,500,000 shares (the
“Underlying Shares”) of the Company’s common stock, par value $0.01 per share (“Common
Stock”);

B. WHEREAS, concurrently with the execution and delivery of this Agreement, the Company and
Yucaipa American Alliance Fund II, LLC, a Delaware limited liability company (“Yucaipa
Manager”), are entering into the Real Estate Fund Formation Agreement, dated as of this date,
in the form attached hereto as Exhibit C (the “Real Estate Fund Formation
Agreement”);

C. WHEREAS, concurrently with the execution and delivery of this Agreement, the Company and
the Investors are entering into a Registration Rights Agreement, dated as of this date, in the form
attached hereto as Exhibit D (the “Registration Rights Agreement” and, together
with the Real Estate Fund Formation Agreement, the “Ancillary Agreements”).

NOW, THEREFORE, in consideration of the foregoing and the promises and representations,
warranties, covenants and agreements contained herein, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be
legally bound hereby, the parties hereto hereby agree as follows:

ARTICLE 1

Defined Terms

 As used in this Agreement, the following terms shall have the following meanings:

“Action” means any suit, action, proceeding (including any compliance, enforcement or
disciplinary proceeding), arbitration, formal or informal inquiry,

 

 

inspection, investigation or formal order of investigation or complaint, or other litigation
of any kind, in each case whether civil, criminal or administrative, at law or in equity.

“Affiliate” of any person means another person that, directly or indirectly, through
one or more intermediaries, controls, is controlled by, or is under common control with, such first
person. A person shall be deemed to control another person if such first person possesses,
directly or indirectly, the power to direct, or cause the direction of, the management and policies
of such other person, whether through the ownership of voting securities, by contract or otherwise;
provided, that, the existence of a management contract primarily for operational services
provided by the Company or an Affiliate of the Company shall not be deemed to be control by the
Company or such Affiliate, as the case may be.

“Agreement” has the meaning assigned to such term in the Preamble.

“Ancillary Agreements” has the meaning assigned to such term in Recital C.

“Applicable Law” means all applicable constitutions, statutes, laws, rules,
regulations, ordinances and Judgments of Governmental Entities.

“Appointment Resolutions” means the resolutions of the Board of Directors (a) to fix
the number of directors of the Board of Directors at nine (9) pursuant to Section 2.1 of the
By-Laws, and (b) to appoint the Investor Nominee to fill the single vacancy of the nine-member
Board of Directors caused by the Resignations pursuant to Article Seventh of the Charter and
Section 2.2 of the By-Laws.

“Benefit Arrangement” means, at any time, an employee benefit plan within the meaning
of Section 3(3) of ERISA which is not a Plan or a Multiemployer Plan and which is maintained or
otherwise contributed to by any member of the ERISA Group.

“Board of Directors” has the meaning assigned to such term in Section 3.2(a).

“Business Day” means any day except Saturday, Sunday or a day on which banking
institutions in the State of New York generally are authorized or required by law to be closed.

“By-Laws” means the By-Laws of the Company, dated as of February 9, 2006, in the form
provided to the Investors as an annex to the secretary’s certificate delivered to the Investors
pursuant to Section 2.2.1(c)(i).

“Capital Lease Obligations” of any person means the obligations of such person to pay
rent or other amounts under any lease of (or other arrangement conveying the right to use) real or
personal property, or a combination thereof, which obligations are required to be classified and
accounted for as capital leases on a balance sheet of such person under GAAP, and the amount of
such obligations shall be the capitalized amount thereof determined in accordance with GAAP.

“Certificate of Designations” has the meaning assigned to such term in Recital A.

 

2

 

“Charter” means the Amended and Restated Certificate of Incorporation of the Company,
as filed with the Secretary of State of the State of Delaware on February 9, 2006, in the form
provided to the Investors as an annex to the secretary’s certificate delivered pursuant to
Section 2.2.1(c)(i).

“Code” means the Internal Revenue Code of 1986, as amended.

“Collective Bargaining Agreement” means any collective bargaining agreement or any
other labor-related agreement with any labor union or labor organization to which the Company or
any of its subsidiaries is a party.

“Common Stock” has the meaning assigned to such term in Recital A.

“Common Stock Board Condition” has the meaning assigned to such term in Section
5.7(b)(i).

“Company” has the meaning assigned to such term in the Preamble.

“Company Disclosure Schedules” has the meaning assigned to such term in the
introductory statement to ARTICLE 3.

“Company Indemnified Parties” has the meaning assigned to such term in Section
6.1(b).

“Company Notice” has the meaning assigned to such term in Section 5.14(b).

“Confidentiality Agreement” means that certain Confidentiality Agreement, dated as of
August 13, 2009, by and between the Company and The Yucaipa Companies, LLC.

“Contract” means any contract, agreement, lease, purchase order, license, mortgage,
indenture, supplemental indenture, line of credit, note, bond, loan, credit agreement, capital
lease, sale/leaseback arrangement, concession agreement, franchise agreement or other instrument,
including all amendments, supplements, exhibits and attachments thereto.

“Designated Transaction” has the meaning assigned to such term in Section 5.6.

“Designated Transaction Notice” has the meaning assigned to such term in Section
5.6.

“Encumbrance” means any lien, encumbrance, security interest, pledge, mortgage,
hypothecation, charge, restriction on transfer of title, adverse claim, title retention agreement
of any nature or kind, or similar claim or right.

“Environmental Laws” means any Applicable Law relating to environmental protection or
the manufacture, storage, remediation, disposal or clean-up of Hazardous Materials including the
following: Clean Air Act, 42 U.S.C. § 7401 et seq.; Federal Water Pollution Control Act, 33 U.S.C.
§ 1251 et seq.; Solid Waste Disposal Act, as amended by the Resource Conservation and Recovery Act,
42 U.S.C. § 6901 et seq.; Comprehensive Environmental Response, Compensation and Liability Act, 42
U.S.C. §

 

3

 

9601 et seq.; National Environmental Policy Act, 42 U.S.C. § 4321 et seq.; regulations of the
Environmental Protection Agency and any applicable rule of common law and any judicial
interpretation thereof relating primarily to the environment or Hazardous Materials.

“ERISA” means the Employee Retirement Income Security Act of 1974, as in effect from
time to time.

“ERISA Group” means the Company, any subsidiary of the Company and all members of a
controlled group of corporations and all trades or businesses (whether or not incorporated) which,
together with the Company or any subsidiary of the Company, are treated as a single employer under
Section 414 of the Code.

“Exchange Act” means the Securities Exchange Act of 1934, as amended.

“Financial Statements” has the meaning assigned to such term in Section
3.12(b).

“GAAP” means generally accepted accounting principles in the United States of America
as in effect from time to time.

“Gaming Authorities” means any Governmental Entity with regulatory control, authority
or jurisdiction over casino, pari-mutuel and lottery or other gaming activities and operations
within the State of Nevada, including the Nevada Gaming Commission, the Nevada State Gaming Control
Board, the Clark County Liquor and Gaming Licensing Board and the City of Las Vegas.

“Gaming Laws” means all Laws pursuant to which any Gaming Authority possesses
regulatory, licensing or permit authority over, casino and pari-mutuel, lottery or other gaming
activities in any jurisdiction, including all rules and regulations established by any Gaming
Authority.

“Governmental Authorizations” means, collectively, all applicable consents, approvals,
permits, orders, authorizations, licenses and registrations, given or otherwise made available by
or under the authority of Governmental Entities or pursuant to the requirements of any Applicable
Law, including liquor licenses, business licenses required for any form of public amusement or
accommodation, and all such consents, approvals, permits, orders, authorizations, licenses and
registrations under Gaming Laws.

“Governmental Entity” means any domestic or foreign, transnational, national, Federal,
state, municipal or local government, or any other domestic or foreign governmental, regulatory or
administrative authority, or any agency, board, department, commission, court, tribunal or
instrumentality thereof.

“Guarantee” means, as to any person, any obligation, contingent or otherwise, of such
person guaranteeing or having the economic effect of guaranteeing any Indebtedness or other
financial obligation of another person (the “primary obligor”) in any manner, whether
directly or indirectly, and including any obligation of such person, direct or indirect, (i) to
purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or
other financial obligation, (ii) to purchase or lease

 

4

 

 property, securities or services for the purpose of assuring the obligee in respect of such
Indebtedness or other obligation of the payment or performance of such Indebtedness or other
financial obligation, (iii) to maintain working capital, equity capital, or any other financial
statement condition or liquidity or level of income or cash flow of the primary obligor so as to
enable the primary obligor to pay such Indebtedness or other financial obligation, or (iv) entered
into for the purpose of assuring in any other manner the obligee in respect of such Indebtedness or
other obligation of the payment or financial performance thereof or to protect such obligee against
loss in respect thereof (in whole or in part). The amount of any Guarantee shall be deemed to be
an amount equal to the stated or determinable amount of the related primary obligation, or portion
thereof, in respect of which such Guarantee is made. The term Guarantee shall not include
endorsements for collection or deposit in the ordinary course of business or non-mandatory rights
to make a remedial payment or to take any action following the failure of performance tests in
connection with management contracts primarily for operational services provided by the Company or
an Affiliate of the Company.

“Hazardous Materials” means all or any of the following: (a) substances that are
defined or listed in, or otherwise classified pursuant to, any applicable Environmental Laws as
“hazardous substances”, “hazardous materials”, “hazardous wastes”, “toxic substances” or any other
formulation intended to define, list or classify substances by reason of deleterious properties
such as ignitability, corrosivity, reactivity, carcinogenicity, reproductive toxicity, “TCLP”
toxicity or “EP toxicity”; (b) oil, petroleum or petroleum derived substances, natural gas, natural
gas liquids or synthetic gas and drilling fluids, produced waters and other wastes associated with
the exploration, development or production of crude oil, natural gas or geothermal resources; (c)
any explosives or any radioactive materials; (d) asbestos and asbestos-containing materials in any
form; (e) toxic mold; (f) lead and lead paint; and (g) polychlorinated biphenyls.

“Hedging Transaction” has the meaning assigned to such term in Section 5.9.

“HSR Act” means Hart Scott Rodino Antitrust Improvements Act of 1976, as amended, and
the rules and regulations promulgated thereunder,

“including” means including, without limitation.

“Indebtedness” of any person means, without duplication, (a) all obligations of such
person for borrowed money or with respect to deposits or advances of any kind, (b) all obligations
of such person evidenced by bonds, debentures, notes or similar instruments, (c) all obligations of
such person upon which interest charges are customarily paid, (d) all obligations of such person
under conditional sale or other title retention agreements relating to property acquired by such
person, (e) all obligations of such person in respect of the deferred purchase price of property or
services (excluding trade accounts payable and other accrued obligations, in each case incurred in
the ordinary course of business), (f) all Indebtedness of others secured by (or for which the
holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any
Encumbrance on property owned or acquired by such person, whether or not the Indebtedness secured
thereby has been assumed, (g) all Guarantees by such person of Indebtedness of others, (h) all
Capital Lease Obligations of such person, (i) all obligations, contingent or otherwise, of such
person as an account party in respect  of

 

5

 

letters of credit and letters of guaranty, and (j) all obligations, contingent or otherwise,
of such person in respect of bankers’ acceptances. The Indebtedness of any person shall include
the Indebtedness of any other entity (including any partnership in which such person is a general
partner) to the extent such person is liable therefor as a result of such person’s ownership
interest in or other relationship with such entity, except to the extent the terms of such
Indebtedness provide that such person is not liable therefor. Notwithstanding the foregoing, in
connection with any acquisition by any person, the term “Indebtedness” shall not include contingent
post-closing purchase price adjustments or earn-outs to which the seller in such acquisition may
become entitled.

“Indemnified Party” has the meaning assigned to such term in Section 6.1(c).

“Indemnitor” has the meaning assigned to such term in Section 6.1(c).

“Intellectual Property” has the meaning assigned to such term in Section 3.5.

“Investor” has the meaning assigned to such term in the Preamble.

“Investor Indemnified Parties” has the meaning assigned to such term in Section
6.1(a).

“Investor Nominee” has the meaning assigned to such term in Section 5.7.

“Investor Proposal” has the meaning assigned to such term in Section 5.6.

“Investor Securities” has the meaning assigned to such term in Recital A.

“Investment Amount” has the meaning assigned to such term in Section 2.1.

“Joint Venture” means any joint venture or similar business entity, whether organized
as a general or limited partnership, limited liability company or otherwise, to which the Company
or any of its subsidiaries is a party, including without limitation each of the “unconsolidated
joint ventures” described to in the Company’s most recent Annual Report on Form 10-K filed pursuant
to the Exchange Act and the rules and regulations thereunder. Any subsidiary of the Company shall
not be a Joint Venture.

“Judgment” means any applicable judgment, order or decree of any Governmental Entity.

“JV Guarantee” has the meaning assigned to such term in Section 3.22(c).

“knowledge of the Company,” “to the Company’s knowledge” or other references
to the “knowledge” of the Company mean the actual knowledge of the particular fact in question by
(i) any officer of the Company who has the title of Executive Vice President or a more senior title
or (ii) any attorney working in the office of the General Counsel of the Company; provided,
that for purposes of Section 3.6, “knowledge of the Company,” “to the Company’s
knowledge” or other references to the “knowledge” of the Company mean the actual knowledge of
the particular fact in question by (x) any officer of the Company who has the title of Executive
Vice President or a more senior title, (y) any attorney working in the office of the General
Counsel of the Company, or (z) the general

 

6

 

 manager (or equivalent) of each of the properties listed on Schedule 3.6 of the
Company Disclosure Schedules.

“Labor Laws” means any Applicable Law relating to employment standards, employee
rights, health and safety, labor relations, workplace safety and insurance or pay equity.

“Losses” means all liabilities, costs, expenses, obligations, losses, damages
(excluding consequential, special, incidental, indirect or punitive damages), penalties, actions,
judgments and claims of any kind or nature (including reasonable attorneys’ fees and expenses
incurred in investigation or defending any of the foregoing).

“Material Adverse Effect” means any material adverse effect on (i) the business,
results of operations or financial condition of the Company and its subsidiaries, taken as a whole
(other than (a) any change, event, occurrence or development that generally affects the industry in
which the Company and its subsidiaries operate and does not disproportionately effect (relative to
other industry participants) the Company and its subsidiaries, (b) any change, event, occurrence or
development to the extent attributable to conditions generally affecting (I) the industries in
which the Company participates that does not have a materially disproportionate effect (relative to
other industry participants) on the Company and its subsidiaries, (II) the U.S. economy as a whole,
or (III) the equity capital markets generally, and (c) any change, event, occurrence or development
that results from any action taken by the Company at the request of an Investor or as required by
the terms of this Agreement or the Ancillary Agreements) or (ii) the ability of the Company to
perform its obligations hereunder or under the Ancillary Agreements.

“Material Contract” means any Contract of a type described in Item 6.01 of Regulation
S-K.

“Material Indebtedness” means, with respect to a person, (a) any Indebtedness of such
person in excess of $5,000,000, or (b) any Contract pursuant to which such person has the right to
incur Indebtedness in excess of $5,000,000.

“Multiemployer Plan” has the meaning assigned to such term in Section 3.10(b).

“Nasdaq” means the Nasdaq Global Select Market (or a successor entity thereto).

“New Securities” means any debt or equity securities of the Company, whether or not
now authorized, and securities or rights of any type issued by the Company that are, or by their
terms may become, convertible into or exchangeable or exercisable for debt or equity securities of
the Company.

“Operating Company” means Morgans Group LLC, a Delaware limited liability company.

“Owned Real Property” has the meaning assigned to such term in Section 3.4(a).

“PBGC” means the Pension Benefit Guaranty Corporation and any successor agency.

 

7

 

“Permitted Encumbrances” means: (i) carriers’, warehousemen’s, mechanics’,
materialmen’s, repairmen’s, landlords’ and other like Encumbrances imposed by law, arising in the
ordinary course of business and securing obligations that are not overdue by more than 30 days or
are being contested in good faith by appropriate proceedings with appropriate reserves established;
(ii) Encumbrances for Taxes, utilities and other governmental charges that, in each case, are not
overdue by more than 30 days or are being contested in good faith by appropriate proceedings with
appropriate reserves established; (iii) pledges and deposits made in the ordinary course of
business pursuant to workers’ compensation, unemployment insurance and other social security laws
or regulations; (iv) deposits to secure the performance of bids, trade contracts, leases, statutory
obligations, surety and appeal bonds, performance bonds and other obligations of a like nature, in
each case in the ordinary course of business; (v) easements, zoning restrictions, rights-of-way and
similar Encumbrances on real property imposed by law or arising in the ordinary course of business
that do not secure any monetary obligations and do not, individually or in the aggregate,
materially detract from the value of the affected property or interfere with the ordinary conduct
of business of the Company and its subsidiaries; (vi) matters of record or registered Encumbrances
affecting title to any owned or leased real property of a person and its subsidiaries, (vii)
statutory Encumbrances of landlords for amounts not yet due and payable; and (viii) de minimis
defects, irregularities or imperfections of title and other Encumbrances which, individually or in
the aggregate, do not materially impair the continued use (in a manner generally consistent with
current use in the business of the person and its subsidiaries) of the asset or property to which
they relate.

“person” means any individual, firm, corporation, partnership, limited liability
company, trust, joint venture, Governmental Entity or other entity.

“Plan” means at any time an employee pension benefit plan (other than a Multiemployer
Plan) which is covered by Title IV of ERISA or subject to the minimum funding standards under
Section 412 of the Internal Revenue Code and either (a) is maintained, or contributed to, by any
member of the ERISA Group for employees of any member of the ERISA Group or (b) has at any time
within the preceding five years been maintained, or contributed to, by any person which is
currently or was at such time a member of the ERISA Group for employees of any person which is
currently or was at such time a member of the ERISA Group.

“Preferred Securities” has the meaning assigned to such term in Recital A.

“Pro Rata Amount” means, at any time with respect to each Investor, as of any date of
determination, the ratio of (i) the number of shares of Common Stock that such Investor holds
(beneficially or of record) or has the right to acquire by exercise of the Warrants or the REF
Warrants (whether or not such Warrants or REF Warrants are then exercisable) as of such date, to
(ii) the total number of shares of Common Stock issued and outstanding as of such date.

“Real Estate Fund Formation Agreement” has the meaning assigned to such term in
Recital B.

 

8

 

“Real Property” means, collectively, the Owned Real Properties and the properties
leased pursuant to the Real Property Leases.

“Real Property Lease” has the meaning assigned to such term in Section 3.4(b).

“Recent Balance Sheet” means the consolidated balance sheet of the Company and its
consolidated subsidiaries as of June 30, 2009 included in the Financial Statements.

“REF Warrants” means the warrants to acquire Common Stock issued to Yucaipa Manager on
the date hereof pursuant to the Real Estate Fund Formation Agreement.

“REF Underlying Shares” means the shares of Common Stock issuable upon exercise of the
REF Warrants.

“Registration Rights Agreement” has the meaning assigned to such term in Recital C.

“Resignations” has the meaning assigned to such term in Section 5.7(a)(i).

“Rights Plan” means the Amended and Restated Stockholder Protection Rights Agreement,
dated as of October 1, 2009, by and between the Company and Mellon Investor Services LLC, as rights
agent.

“Rights Plan Amendment” means the amendment to the Rights Plan in the form attached
hereto as Exhibit E.

“ROFR Notice” has the meaning assigned to such term in Section 5.14(a).

“Rules” has the meaning assigned to such term in Section 5.3.

“SEC” means the Securities and Exchange Commission.

“SEC Reports” has the meaning assigned to such term in Section 3.12(a).

“Securities Act” means the Securities Act of 1933, as amended.

“SOX” means the Sarbanes-Oxley Act of 2002.

“subsidiary” of any person means, on any date, any person the accounts of which would
be consolidated with and into those of the first person in such person’s consolidated financial
statements if such financial statement were prepared in accordance with GAAP.

“Surviving Representation” has the meaning assigned to such term in Section
6.1.

“Tax” means any foreign, Federal, state or local income, sales and use, excise,
franchise, real and personal property, gross receipt, capital stock, production, business and
occupation, disability, estimated, employment, payroll, severance or withholding tax, value-added
tax or other tax, duty, fee, impost, levy, assessment or charge imposed by

 

9

 

 
any taxing authority, and any interest or penalties and other additions to tax related
thereto.

“Tax Returns” means any return, report, claim for refund, declaration, information
return or other document required to be filed with any Tax authority with respect to Taxes,
including any amendments thereof.

“Third Party” means any person other than the Company, the Investors, or any of their
respective subsidiaries or Affiliates.

“Third Party Claim” has the meaning assigned to such term in Section 6.1(c).

“Underlying Shares” has the meaning assigned to such term in Recital A.

“Voting Debt” means bonds, debentures, notes or other debt securities having the right
to vote (or convertible into, or exchangeable for, securities having the right to vote) generally
in the election of directors of the Company or other matters on which holders of the Common Stock
may vote.

“Voting Stock” of any person means securities having the right to vote generally in
any election of directors or comparable governing persons of any such person.

“Warrant” has the meaning assigned to such term in Recital A.

“YAAF II” and “YAAF II-P” have the respective meanings assigned to such terms
in the Preamble.

“Yucaipa Manager” has the meaning assigned to such term in Recital B.

ARTICLE 2

Issuance and Sale of Investor Securities

2.1 Issuance and Sale of the Investor Securities. On the terms and subject to the conditions
set forth in this Agreement, the Company hereby issues, sells and delivers in certificated form to
the Investors, and the Investors hereby purchase from the Company, the Investor Securities for an
aggregate cash purchase price of $75,000,000 (the “Investment Amount”).

2.2 Deliveries.

2.2.1 Concurrently with the execution and delivery of this Agreement, the Company will deliver
to:

	 	(a)	 	YAAF II a certificate representing 45,213
shares of Preferred Securities and a Warrant to acquire 7,535,580
shares of Common Stock, and

 

10

 

	 	(b)	 	YAAF II-P a certificate representing 29,787
shares of Preferred Securities and a Warrant to acquire 4,964,420
shares of Common Stock;

	 	(c)	 	The Investors:

(i) a secretary’s certificate, dated as of the date hereof,
executed by the Company’s secretary, in the form attached hereto
as Exhibit F,

(ii) a duly executed counterpart of each Ancillary Agreement to
which the Company is a party, and

(iii) an opinion letter of Sullivan & Cromwell LLP, as counsel to
the Company, dated as of the date hereof, in the form attached
hereto as Exhibit G;

	 	(d)	 	Yucaipa Manager (or person(s) designated by
the Investors in writing) payment by wire transfer to the bank
account specified in Schedule 2.2.1(d) of $600,000 in payment
of costs and expenses incurred in connection with this Agreement and
the transactions contemplated hereby (such payment being made
pursuant to Section 5.2(a)); and

	 	(e)	 	Yucaipa Manager payment by wire transfer to
the bank account specified in Schedule 2.2.1(d) of the
commitment fee pursuant to Section 5.2(b).

2.2.2 Concurrently with the execution and delivery of this Agreement, the following have been
delivered to the Company by the applicable Investor:

	 	(a)	 	Payment of a portion of the Investment
Amount by wire transfer to the bank account of the Company specified
in Schedule 2.2.2(a) in the following amounts:

	 	(i)	 	From YAAF II: $45,213,478.50, and

	 	(ii)	 	From YAAF II-P: $29,786,521.50;

	 	(b)	 	An opinion letter of Munger, Tolles & Olson
LLP, dated as of the date hereof, in the form attached hereto as
Exhibit H; and

	 	(c)	 	A duly executed counterpart of each
Ancillary Agreement to which each Investor or an Affiliate of the
Investors is a party.

2.3 Allocation of Investment Amount. The Company and the Investors agree to allocate the
Investment Amount for all purposes, including financial accounting

 

11

 

and Tax purposes, $69,000,000 to the aggregate Preferred Securities issued hereby and
$6,000,000 to the aggregate Warrants issued hereby. Neither the Company nor any Investor shall
take any position inconsistent with such allocation unless required to do so by Applicable Law.

ARTICLE 3

Representations and Warranties

of the Company

Subject to the qualifications set forth in the corresponding sections of the disclosure
schedules delivered by the Company to the Investors concurrently with the execution and delivery of
this Agreement (the “Company Disclosure Schedules”) or in the SEC Reports (other than any
“Risk Factors” section or “forward-looking statements” contained therein, any exhibits thereto, and
any documents incorporated by reference therein), the Company hereby represents and warrants to the
Investors as follows:

3.1 Entity Status. Each of the Company and its subsidiaries is duly incorporated or otherwise
organized, validly existing and in good standing under the Applicable Laws of its governing
jurisdiction and each has all requisite corporate or other power and authority to carry on its
business as it is now being conducted and is duly qualified to do business in each of the
jurisdictions in which the ownership, operation or leasing of its assets or the conduct of its
business requires it to be so qualified, except where the failure to have such corporate or other
power or authority or to be in good standing or so qualified, has not had and would not reasonably
be expected to have a Material Adverse Effect, and no proceeding has been instituted in any such
jurisdiction revoking, limiting or curtailing, or seeking to revoke, limit or curtail, such power,
authority or qualification.

3.2 Authorization; Noncontravention.

(a) Authorization. The Company has all necessary corporate power and authority to
execute and deliver this Agreement and the Ancillary Agreements, to perform its obligations
hereunder and thereunder, and to consummate the transactions contemplated hereby and thereby. The
Company has delivered to the Investors a true and correct copy, certified by the Company’s
secretary, of the resolutions of its board of directors (the “Board of Directors”)
authorizing the execution and delivery of this Agreement and consummation of the transactions
contemplated by this Agreement. Such resolutions are in full force and effect, have not been
amended, supplemented, revoked or superseded as of the date hereof and are the only resolutions of
the Board of Directors pertaining to the authorization, execution and delivery of this Agreement
and the Ancillary Agreements and consummation of the transactions contemplated hereby and thereby.
The execution, delivery and performance of this Agreement and the Ancillary Agreements and the
consummation by the Company of the transactions contemplated hereby and thereby, including the
issuance (or reservation for issuance), sale and delivery of the Investor Securities, the
Underlying Shares, the REF Warrants and the REF Underlying Shares and any redemptions of such
Warrants and REF Warrants pursuant to the terms thereof, have been duly and validly authorized by
all necessary corporate action, and no other corporate proceedings on the part of the

 

12

 

 Company or its subsidiaries or (except as contemplated by Section 5.3) vote of holders
of any class or series of capital stock of the Company or its subsidiaries is necessary to
authorize this Agreement or the Ancillary Agreements or to consummate the transactions contemplated
hereby and thereby. This Agreement and the Ancillary Agreements have been duly executed and
delivered by the Company and (assuming due authorization, execution and delivery by each other
party thereto) each constitutes, a valid and binding obligation of the Company, enforceable against
the Company in accordance with its terms, except as enforceability may be limited by bankruptcy,
insolvency, reorganization, moratorium and other similar laws relating to or affecting creditors’
rights generally or by general equitable principles (regardless of whether such enforceability is
considered in a proceeding in equity or at law); provided, that no representation is made
hereby with respect to the enforceability of Section 5.7(b)(ii)(4).

(b) Preemptive Rights; Rights of First Offer. None of the sale and issuance of the
Investor Securities pursuant to this Agreement and the issuance of Underlying Shares upon exercise
thereof, or the issuance of the REF Warrants pursuant to the Real Estate Fund Formation Agreement
and the issuance of the REF Underlying Shares upon exercise thereof, is or will be subject to any
preemptive rights, rights of first offer or similar rights of any person.

(c) No Conflict. The Company is not in violation or default of any provision of its
Charter or By-Laws. Except as set forth in Schedule 3.2(c) of the Company Disclosure
Schedules, the execution, delivery and performance by the Company of this Agreement and the
Ancillary Agreements do not, and the consummation of the transactions contemplated hereby and
thereby and compliance with the provisions hereof and thereof will not, result in a “change of
control” (or similar event) under, or conflict with, or result in any default under, or give rise
to an increase in, or right of termination, cancellation, acceleration or mandatory prepayment of,
any obligation or to the loss of a benefit under, or result in the suspension, revocation,
impairment, forfeiture or amendment of any term or provision of or the creation of any Encumbrance
upon any of the properties or assets of the Company or any of its subsidiaries under, or require
any consent or waiver under, any provision of (i) the Charter, the By-Laws or the comparable
organizational documents of any of the Company’s subsidiaries, (ii) any Material Contract, (iii)
any Material Indebtedness, (iv) any Collective Bargaining Agreement, Multiemployer Plans or Benefit
Plans or (v) any Applicable Law, Judgment or Governmental Authorization, in each case applicable to
the Company and its subsidiaries or their respective assets, except in the case of (ii), (iii),
(iv) or (v), to the extent it does not or would not reasonably be expected to have, individually or
in the aggregate, a Material Adverse Effect. No Governmental Authorization, order or authorization
of, or registration, qualification, declaration or filing with, or notice to, any Governmental
Entity is required to be obtained or made by or with respect to the Company or any of its
subsidiaries in connection with the execution, delivery and performance of this Agreement or any of
the Ancillary Agreements or the other transactions contemplated by this Agreement or the Ancillary
Agreements, including the issuance of the Investor Securities, the Underlying Shares, the REF
Warrants and the REF Underlying Shares (and any redemptions of the Warrants or REF Warrants
pursuant to the terms thereof), except for (A) authorization of, or registration, qualification,
declaration or filing with, or notice to, Gaming Authorities (which have been, or will be at the
time required, duly

 

13

 

performed by the Company), (B) notice to or consultation with Nasdaq (which has been, or will
be at the time required, duly performed by the Company), and (C) such Governmental Authorizations,
orders, authorizations, registrations, declarations, filings and notices, the failure of which to
be obtained or made would not materially impair the Company’s ability to perform its obligations
under this Agreement or the Ancillary Agreements or to consummate the transactions contemplated
hereby or thereby. Except as set forth in Schedule 3.2(c) of the Company Disclosure
Schedules, neither the execution and delivery of this Agreement, nor the consummation of the
transactions contemplated hereby, either alone or in combination with another event (whether
contingent or otherwise) will, to the knowledge of the Company, (1) result in the payment of any
“excess parachute payment” under Section 280G of the Code, (2) entitle any current or former
employee, consultant or director of the Company or any of its subsidiaries to any material payment
other than pursuant to the terms of the Real Estate Fund Formation Agreement, (3) increase the
amount of compensation or benefits due to any such employee, consultant or director other than
pursuant to the terms of the Real Estate Fund Formation Agreement, or (4) accelerate the vesting,
funding or time of payment of any compensation, equity award or other benefit. After giving effect
to the Rights Plan Amendment, none of the execution and delivery of this Agreement, the execution
and delivery of any of the Ancillary Agreements, or the consummation of any of the transactions
contemplated hereby or thereby (including the issuance of the Warrants and the Underlying Shares
upon exercise thereof and the issuance of the REF Warrants and the REF Underlying Shares upon
exercise thereof) shall give any person the right to purchase any securities of the Company
pursuant to, or shall otherwise trigger any comparable provisions under, the Rights Plan.

3.3 Capital Structure.

(a) The authorized capital stock of the Company consists of 200,000,000 shares of Common Stock
and 40,000,000 shares of preferred stock. Of the 200,000,000 authorized shares of Common Stock,
29,648,096 shares are issued and outstanding, and only the following are reserved for issuance:
12,500,000 shares reserved for issuance in connection with the exercise of the Warrants, 6,415,327
shares reserved for issuance in connection with the exercise of warrants issued pursuant to hedging
transactions, 5,000,000 shares reserved for issuance in connection with the exercise of the REF
Warrants, and 16,468,755 shares reserved for issuance pursuant to the Company’s 2007 Amended and
Restated Omnibus Incentive Plan and the Company’s 2.375% Senior Subordinated Convertible Notes due
2014. Of the 40,000,000 authorized shares of preferred stock, the only shares issued and
outstanding are the Preferred Securities issued to the Investors, and no other shares of such
preferred stock are reserved for issuance.

(b) Each share of Common Stock is duly authorized, validly issued, fully paid and
nonassessable. The Preferred Securities, Warrants, Underlying Shares, REF Warrants, and REF
Underlying Shares, have been duly authorized and are, or to the extent issued after the date hereof
are reserved and will upon issuance be: (i) solely with respect to the Preferred Securities,
Underlying Shares and REF Underlying Shares, validly issued, fully paid and nonassessable, (ii) not
issued in violation of any purchase option, call option, right of first refusal, preemptive right,
subscription right or any similar right under any provision of the Charter or By-Laws of the
Company or any Contract to which the Company or any of its subsidiaries is a party or by which any
of its

 

14

 

 

or their respective assets are bound, and (iii) free and clear of all Encumbrances (other than
any Encumbrances created by the Investors). The Company has not issued any Voting Debt. Except as
set forth in Schedule 3.3(b) of the Company Disclosure Schedules, there are no (A)
outstanding obligations, options, warrants, convertible securities, exchangeable securities,
securities or rights that are linked to the value of the Common Stock or other rights, agreements
or commitments relating to the capital stock of the Company or that obligate the Company to issue
or sell or otherwise transfer shares of capital stock of the Company or any securities convertible
into or exchangeable for any shares of capital stock of the Company or any Voting Debt of the
Company, (B) outstanding obligations of the Company to repurchase, redeem or otherwise acquire
shares of capital stock of the Company, (C) voting trusts, stockholder agreements, proxies or other
agreements or understandings in effect with respect to the voting or transfer of shares of capital
stock of the Company (but only to the Company’s knowledge with respect to any such agreements to
which neither the Company nor any subsidiary of the Company is a party), or (D) rights of first
refusal, preemptive rights, subscription rights or any similar rights with respect to the capital
stock of the Company under the Charter or By-Laws or any Contract to which the Company or any
subsidiary of the Company is a party or by which any of its assets are bound. No provision of the
Charter or the By-Laws would, directly or indirectly, restrict or impair the ability of the
Investors or Yucaipa Manager, as applicable, to vote, or otherwise exercise the rights of a
stockholder with respect to, the Preferred Securities, the Underlying Shares or the REF Underlying
Shares, except as expressly set forth in the Certificates of Designations. Other than the Rights
Plan, the Company does not have a “stockholder rights plan” or “poison pill” or any similar
arrangement in effect.

(c) Schedule 3.3(c) of the Company Disclosure Schedules sets forth a complete and
accurate list of all subsidiaries of the Company and all Joint Ventures, including in each case
each such entity’s name, its form of organization, its jurisdiction of incorporation or
organization and the percentage of its outstanding capital stock or equity interests owned by the
Company, a subsidiary of the Company or a Joint Venture (as applicable). The shares of outstanding
capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable.
Except as set forth in Schedule 3.3(c) of the Company Disclosure Schedules, the shares of
outstanding capital stock or equity interests of the Company’s subsidiaries are (with respect to
the Company’s material subsidiaries only) duly authorized, validly issued, fully paid and
nonassessable, and (with respect to all of the Company’s subsidiaries) are held of record and
beneficially owned by the Company or a subsidiary of the Company (as applicable). Except as set
forth in Schedule 3.3(c) of the Company Disclosure Schedules, the shares of capital stock
or equity interests of each Joint Venture that are owned by the Company or any subsidiary of the
Company are duly authorized, validly issued, fully paid and nonassessable, and are held of record
and beneficially owned by the Company or a subsidiary of the Company (as applicable). There is no
Voting Debt of any subsidiary of the Company. Except as set forth in Schedule 3.3(c) of
the Company Disclosure Schedules, there are no (i) outstanding obligations, options, warrants,
convertible securities, exchangeable securities, securities or rights that are linked to the value
of the Common Stock or other rights, agreements or commitments, in each case, relating to the
capital stock or equity interests of the subsidiaries of the Company or that obligate the Company
or its subsidiaries to issue or sell or otherwise transfer shares of the capital

 

15

 

 

stock or any securities convertible into or exchangeable for any shares of capital stock or
any Voting Debt of any subsidiary of the Company, (ii) outstanding obligations of the subsidiaries
of the Company to repurchase, redeem or otherwise acquire shares of their respective capital stock
or equity interests, (iii) voting trusts, stockholder agreements, proxies or other agreements or
understandings in effect with respect to the voting or transfer of shares of capital stock of the
subsidiaries of the Company (but only to the Company’s knowledge with respect to any such
agreements to which neither the Company nor any subsidiary of the Company is a party), or (iv)
rights of first refusal, preemptive rights, subscription rights or any similar rights under any
provision of the governing documents of any subsidiary of the Company.

(d) Other than the subsidiaries of the Company, the Joint Ventures and the subsidiaries
thereof and other than as set forth in Schedule 3.3(c) of the Company Disclosure Schedules,
there are no persons in which any of the Company or its subsidiaries owns any equity, membership,
partnership, joint venture or other similar interest with a value in excess of $1,000,000.

3.4 Real Property.

(a) As of the date hereof, the Company and its subsidiaries own in fee simple the real
property listed in Schedule 3.4(a) of the Company Disclosure Schedules (the “Owned Real
Property”). The Company or the subsidiary indicated on such schedule has good and marketable
title in fee simple, free and clear of Encumbrances (other than those set forth on Schedule
3.4(a) of the Company Disclosure Schedules and Permitted Encumbrances), to each Owned Real
Property. Neither the Company nor any of its subsidiaries has received notice of any pending, and
to the Company’s knowledge there is no threatened, condemnation

proceeding with respect to any of
the Owned Real Property.

(b) Schedule 3.4(b) of the Company Disclosure Schedules lists all material leases and
subleases, including all amendments, assignments, supplements and, to the Company’s knowledge,
modifications thereto, under which the Company or any of its subsidiaries uses or occupies or has
the right to use or occupy any real property and all material tenant leases and subleases as to
which the Company or any of its subsidiaries is the lessor (the “Real Property Leases”) and
specifies the remaining term of each Real Property Lease with respect to which the Company or any
of its subsidiaries is the lessee and the amounts of rent payable per year thereunder. Each Real
Property Lease is valid, binding and in full force and effect and no termination event (other than
expirations in the ordinary course), notice of termination or non-renewal or condition or uncured
default (or event which with notice or lapse of time, or both, would constitute a default) of a
material nature on the part of the Company or the applicable subsidiary or the other party
thereunder, exists under any Real Property Lease. The Company or the applicable subsidiary has a
good and valid leasehold interest in each parcel of real property as to which it is a tenant under
a Real Property Lease, and, to the Company’s knowledge, such leasehold estate is free and clear of
all Encumbrances other than those set forth on Schedule 3.4(b) of the Company Disclosure
Schedules and Permitted Encumbrances or those imposed by the applicable Real Property Leases. As
of the date hereof, neither the Company nor any subsidiary of the Company has received notice of
any pending, and to the Company’s knowledge there is no threatened, condemnation

 

16

 

proceedings with respect to any property leased pursuant to any of the Real Property Leases.

(c) Neither the Company nor any subsidiary of the Company uses or occupies any real property
in the ordinary course of the business of the Company and its subsidiaries, other than the Owned
Real Property, properties that are the subject of leases where the Company or any of its
subsidiaries is the lessor, properties that are the subject of management or similar agreements
under which the Company or any of its subsidiaries manages any portion of the businesses located on
such real property, easements and properties that are the subject of a Real Property Lease.

3.5 Intellectual Property. Each of the Company and each of its subsidiaries owns, or has the
right to use, all software, patents, trademarks, service marks, trade names, trade secrets and
copyrights (collectively, “Intellectual Property”) material to the conduct of its
businesses as currently conducted. Except as set forth on Schedule 3.5 of the Company
Disclosure Schedules, since January 1, 2008, no material Action has been filed or threatened in
writing by any person (i) with respect to the use of any such Intellectual Property by the Company
or any subsidiary of the Company, (ii) challenging or questioning the validity of any such
Intellectual Property owned by the Company or any subsidiary of the Company, or (iii) to the
Company’s knowledge, challenging or questioning the validity of any such Intellectual Property that
is used but not owned by the Company or any subsidiary of the Company. To the Company’s knowledge,
the use of such Intellectual Property by the Company and its subsidiaries does not infringe on the
rights of any person, except for such infringements as would not reasonably be expected to,
individually or in the aggregate, give rise to any liabilities on the part of the Company or any of
its subsidiaries that would reasonably be expected to have a Material Adverse Effect.

3.6 Environmental Matters. Each of the Company and its subsidiaries has obtained all
Governmental Approvals which are required under Environmental Laws for the operation of the
business as presently conducted and is in compliance with all terms and conditions of such
Governmental Approvals, except as would not, individually or in the aggregate, be reasonably
expected to have a Material Adverse Effect. Except for any of the following matters that would not,
individually or in the aggregate, be reasonably expected to have a Material Adverse Effect, (i) the
Company does not have knowledge of, and has not received any written notice of, any past, present,
or future events, conditions, circumstances, activities, practices, incidents, actions, or plans
that, with respect to the Company, any subsidiary of the Company or any of the Real Property, that
would reasonably be expected to prevent compliance or continued compliance with Environmental Laws,
or give rise to any common-law or legal liability, or otherwise form the basis of any claim,
action, demand, suit, proceeding, hearing, study, or investigation, based on or related to the
manufacture, processing, distribution, use, treatment, storage, disposal, transport, or handling or
the emission, discharge, release or threatened release into the environment, of any Hazardous
Material, and (ii) there is no Action pending or, to the Company’s knowledge, threatened, against
the Company or any subsidiary of the Company relating to Environmental Laws. Notwithstanding any
other representation and warranty in this Article 3, the representations and warranties contained
in this Section 3.6 constitute the sole representations and warranties of the Company
relating to any Environmental Law.

 

17

 

3.7 Legal Proceedings. Except as set forth in Schedule 3.7 of the Company Disclosure
Schedules, there are no Actions pending or, to the Company’s knowledge, threatened, against the
Company or any of its subsidiaries, which, if adversely determined, would reasonably be expected to
have a Material Adverse Effect. There are no Actions pending or, to the Company’s knowledge,
threatened against the Company or any of its subsidiaries, which, if adversely determined, would
materially impair the Company’s ability to perform its obligations under this Agreement or the
Ancillary Agreements or challenge the validity or enforceability of this Agreement or any Ancillary
Agreement or seek to enjoin or prohibit the consummation of the transactions contemplated hereby or
thereby. None of the Company or any of its subsidiaries is in default with respect to any material
Judgment.

3.8 Taxes.

(a) Except as disclosed in the SEC Reports or in Schedule 3.8 of the Company
Disclosure Schedules or except as would not reasonably be expected, individually or in the
aggregate, to have a Material Adverse Effect: (i) the Company and each of its subsidiaries have
filed all Tax Returns required to be filed by them; (ii) all such Tax Returns are true, correct and
complete; (iii) all Taxes due and owed by the Company and its subsidiaries (whether or not shown on
any Tax Return) have been paid; (iv) neither the Company nor any of its subsidiaries currently is
the beneficiary of any extension of time within which to file any Tax Return; (v) no claim has ever
been made by a Governmental Authority in a jurisdiction where the Company or any of its
subsidiaries does not file Tax Returns that the Company or any such subsidiary is or may be subject
to taxation by that jurisdiction; (vi) there are no liens on any of the assets or properties of the
Company or any of its subsidiaries that arose in connection with any failure (or alleged failure)
to pay any Tax; (vii) there are no ongoing, pending or, to the Company’s knowledge, threatened
audits, assessments, or other proceedings for or relating to any liability in respect of Taxes of
the Company or any of its subsidiaries; (viii) neither the Company nor any of its subsidiaries has
waived any statute of limitations in respect of Taxes or agreed to any extension of time with
respect to a Tax assessment or deficiency; and (ix) the Company and each of its subsidiaries have
timely withheld and paid all Taxes required to have been withheld and paid in connection with
amounts paid or owing to any employee, independent contractor, creditor, stockholder or other third
party.

(b) There are no Tax sharing agreements or similar arrangements (including indemnity
arrangements) with respect to or involving the Company or any of its subsidiaries. Since February
17, 2006, neither the Company nor any of its subsidiaries has been a member of any affiliated group
filing a consolidated Federal income Tax Return other than a group the common parent of which is
the Company. Except pursuant to customary gross-up, tax escalation or similar provisions in
financing and commercial Contracts entered into in the ordinary course of business, neither the
Company nor any of its subsidiaries has any actual or potential liability for the Taxes of any
person (other than Taxes of the Company and its subsidiaries) under Treasury Regulations Section
1.1502-6 (or any similar provision of foreign, state or local law), as a transferee or successor,
by Contract, or otherwise.

 

18

 

3.9 Labor. Except as set forth on Schedule 3.9 of the Company Disclosure Schedules,
neither the Company nor any of its subsidiaries is party to any Collective Bargaining Agreement.
Except as set forth on Schedule 3.9 of the Company Disclosure Schedules, no Collective
Bargaining Agreement currently is being negotiated by the Company or any of its subsidiaries. None
of the Company or any of its subsidiaries has any obligation to inform or consult with any
employees or their representatives in respect of the transactions contemplated hereby under the
terms of any Collective Bargaining Agreement or Applicable Law, except where the failure to so
inform or consult would not reasonably be expected to have a Material Adverse Effect. There has
not been (i) since January 1, 2008, any work stoppage, slowdown, lockout, employee strike or, (ii)
since January 1, 2009, to the Company’s knowledge any labor union organizing activity involving any
of the Company and its subsidiaries and, (iii) since January 1, 2009, to the Company’s knowledge,
none of the foregoing or any material labor dispute or Action has been threatened in writing. The
Company and its subsidiaries are operating their respective businesses in compliance with all Labor
Laws, except as would not reasonably be expected to have a Material Adverse Effect. Except as set
forth on Schedule 3.9 of the Company Disclosure Schedules, as of the date hereof, to the
Company’s knowledge, there are no ongoing union certification drives or pending proceedings for
certifying a union with respect to employees of any of the Company or any of its subsidiaries.
None of the Company or its subsidiaries is in material breach or material default under any
Collective Bargaining Agreement.

3.10 Employee Benefit Plans.

(a) Each member of the ERISA Group is in compliance with its obligations under the minimum
funding standards of ERISA and the Code with respect to each Plan and is in compliance with the
presently applicable provisions of ERISA and the Code with respect to each Plan, except in each
case for noncompliances which could not reasonably be expected to have a Material Adverse Effect.
No member of the ERISA Group has (i) sought a waiver of the minimum funding standard under Section
412 of the Code in respect of any Plan, (ii) failed to make any contribution or payment to any Plan
or Multiemployer Plan or in respect of any Benefit Arrangement, or made any amendment to any Plan
or Benefit Arrangement, which has resulted or could result in the imposition of a Lien or the
posting of a bond or other security under ERISA or the Code or (iii) incurred any liability under
Title IV of ERISA other than a liability to the PBGC for premiums under Section 4007 of ERISA.
None of the assets of the Company or its subsidiaries constitutes “plan assets” within the meaning
of ERISA, the Code and the respective regulations promulgated thereunder. The execution, delivery
and performance of this Agreement and the Ancillary Agreements do not and will not constitute
“prohibited transactions” under ERISA or the Code.

(b) No withdrawal liability in an aggregate amount in excess of $5,000,000 has been incurred
under Title IV of ERISA by any member of the ERISA Group with respect to any “multiemployer plan”
(as defined in Section 3(37) or 4001(a)(3) of ERISA) which is or has been contributed to by such
person at any time during the six-year period ending on the date of this Agreement or as to which
any member of the ERISA

 Group has any liability (the “Multiemployer Plans”), and no such
liability would be incurred if any member of the ERISA Group were to withdraw from any
Multiemployer Plan in a complete or partial withdrawal. No member of the ERISA

 

19

 

 Group has agreed with any person to be responsible for any liability under Title IV of ERISA
with respect to any multiemployer plan within the meaning of Section 3(37) or 4001(a)(3) of ERISA.

3.11 Compliance with Laws.

(a) Except as disclosed in the SEC Reports or in Schedule 3.11 of the Company
Disclosure Schedules, the Company and each of its subsidiaries and the conduct and operation of
their respective businesses are and have been, since January 1, 2008, (A) in compliance with (1)
each Applicable Law that affects or relates to this Agreement or the Ancillary Documents and (2)
each Applicable Law that is applicable to the Company or its subsidiaries or their respective
businesses, including any laws relating to employment practices, except as would not, individually
or in the aggregate, reasonably be expected to cause a Material Adverse Effect; and (B) in
compliance in all material respects with all applicable Gaming Laws.

(b) Neither the Company nor any of its subsidiaries has received any written notice or other
written communication from any Governmental Entity or any other person regarding (1) any actual,
alleged, possible or potential violation of or failure to comply with any material term or
requirement of any Governmental Authorization, or (2) any actual, proposed, possible or potential
revocation, withdrawal, suspension, cancellation, termination of or modification to any
Governmental Authorization, other than such as would not, individually or in the aggregate, have a
Material Adverse Effect.

3.12 SEC Reports and Company Financial Statements.

(a) Since February 17, 2006, the Company has filed all reports, schedules, forms, statements
and other documents required to be filed by it with the SEC pursuant to the reporting requirements
of the Exchange Act (all the foregoing filed prior to the date hereof and all exhibits included or
incorporated by reference therein and financial statements and schedules thereto and documents
included or incorporated by reference therein being sometimes hereinafter collectively referred to
as the “SEC Reports”). Since January 1, 2008 all of the SEC Reports have been timely filed
with the SEC pursuant to the reporting requirements of the Exchange Act. As of their respective
filing dates, the SEC Reports complied in all material respects with the requirements of the
Exchange Act applicable to the SEC Reports (as amended or supplemented), and none of the SEC
Reports, at the time they were filed with the SEC, contained any untrue statement of a material
fact or omitted to state a material fact required to be stated therein or necessary in order to
make the statements therein, in light of the circumstances under which they were made, not
misleading. Except as set forth on Schedule 3.12 of the Company Disclosure Schedules, no
subsidiary of the Company is required to be, a registrant with the SEC.

(b) As of their respective dates, except as set forth therein or in the notes thereto, the
financial statements contained in the SEC Reports and the related notes (the “Financial
Statements”) complied as to form in all material respects with all applicable accounting
requirements and the published rules and regulations of the SEC with respect thereto. The
Financial Statements (i) were prepared in accordance with

 

20

 

 
 GAAP,
 consistently applied during the periods involved (except (x) as may be otherwise
indicated in the notes thereto or (y) in the case of unaudited interim statements, to the extent
that they may not include footnotes or may be condensed or summary statements), (ii) fairly present
in all material respects the consolidated financial position of the Company and its consolidated
subsidiaries as of the dates thereof and the consolidated results of their operations and cash
flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end
audit adjustments) and (iii) are in all material respects in accordance with the books of account
and records of the Company and its consolidated subsidiaries (except as may be otherwise noted
therein).

(c) Except as disclosed in the SEC Reports or in Schedule 3.12 of the Company Disclosure
Schedules, neither the Company nor any of its subsidiaries has any material liability (whether
known or unknown, whether absolute or contingent, whether liquidated or unliquidated, whether due
or to become due), except for the following: (i) liabilities reflected in or reserved for in the
Recent Balance Sheet, (ii) liabilities that have arisen since the date of the Recent Balance Sheet
in the ordinary course of the businesses of the Company and its subsidiaries consistent with past
practice, (iii) liabilities that (A) would not be required under GAAP to be reflected in an audited
consolidated balance sheet of the Company and its consolidated subsidiaries and (B) are not in the
aggregate material and (iv) liabilities incurred in connection with this Agreement and the
Ancillary Agreements and the performance by the Company of its obligations thereunder.

(d) Neither the Company nor any of its subsidiaries is a party to, or has any commitment to
become a party to, any joint venture, off-balance sheet partnership or any similar Contract or
arrangement (including any Contract relating to any transaction or relationship between or among
the Company and any of its subsidiaries, on the one hand, and any unconsolidated affiliate of the
Company or any of its subsidiaries, including any structured finance, special purpose or limited
purpose entity or person, on the other hand, or any “off-balance sheet arrangements” (as defined in
Item 303(a) of Regulation S-K of the SEC)), where the result, purpose or effect of such Contract is
to avoid disclosure of any material transaction involving, or material liabilities of, the Company
or any of its subsidiaries in the Company’s or such subsidiary’s audited financial statements or
other SEC Reports.

(e) The audit committee of the Board of Directors has established “whistleblower” procedures
that meet the requirements of Rule 10A-3 promulgated under the Exchange Act.

(f) The Company and its subsidiaries have implemented and maintain disclosure controls and
procedures (as defined in Rule 13a-15(f) promulgated under the Exchange Act) that comply in all
material respects with the requirements of the Exchange Act and the rules and regulations
thereunder and have been designed by, or under the supervision of, their respective principal
executive and principal financial officers, or persons performing similar functions, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with GAAP. The Company and its
subsidiaries maintain internal accounting controls sufficient to provide reasonable assurance that
(i) transactions are executed in accordance with management’s general or specific

 

21

 

 

 authorizations; (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability; (iii) access to assets is
permitted only in accordance with management’s general or specific authorization; and (iv) the
recorded accountability for assets is compared with the existing assets at reasonable intervals and
appropriate action is taken with respect to any differences. The Company has disclosed, based on
its most recent evaluation prior to the date of this Agreement, to the Company’s outside auditors
and the audit committee of the Board of Directors (A) any significant deficiencies and material
weaknesses in the design or operation of “internal control over financial reporting” (as defined in
Rule 13a-15(f) promulgated under the Exchange Act) that are reasonably likely to adversely affect
the Company’s ability to record, process, summarize and report financial information, and (B) any
fraud, whether or not material, that involves management or other employees who have a significant
role in the Company’s internal controls over financial reporting.

(g) To the Company’s knowledge, there is no reason that its outside auditors and its chief
executive officer and chief financial officer will not be able to give the certifications and
attestations required pursuant to the rules and regulations adopted pursuant to Section 404 of SOX,
without qualification, when next due.

(h) Except as set forth on Schedule 3.12 of the Company Disclosure Schedules or as
disclosed in the SEC Reports and except as contemplated by the Real Estate Fund Formation
Agreement, none of the executive officers, directors or related persons (as defined in Regulation
S-K Item 404) of the Company is presently a party to any transaction with the Company or any of its
subsidiaries that would be required to be reported on Form 10-K by Item 13 thereof pursuant to
Regulation S-K Item 404.

(i) Set forth on Schedule 3.12 of the Company Disclosure Schedules is a true and
correct list of all Material Indebtedness of the Company and its subsidiaries incurred since June
30, 2009. Except as set forth on Schedule 3.12 of the Company Disclosure Schedules or as
disclosed in the SEC Reports, neither the Company nor any of its subsidiaries is, after giving
effect to this Agreement, (A) in default in the payment of any Material Indebtedness or (B) in
breach or default under any Material Contract evidencing or relating to Indebtedness in any manner
that would permit (or that with notice, lapse of time, or both, would permit) any party to any such
Material Contract to cause such Indebtedness to become due and payable before its stated maturity
or before its regularly scheduled date of payment or to cause the Company or any of its
subsidiaries a reduction or loss in a material respect of rights or benefits under, or an increase
in a material respect of any obligation under, any such Material Contract.

3.13 Material Contracts.

(a) The SEC Reports as supplemented by Schedule 3.13(a) of the Company Disclosure
Schedules, contain a complete and accurate list of all Material Contracts to which the Company and
its subsidiaries are parties.

(b) (i) Each Material Contract, assuming such Material Contract is a legal, valid and binding
obligation of and enforceable against the other parties thereto in accordance with its terms,
constitutes a valid and binding obligation of

 

22

 

the Company or the subsidiary of the Company party thereto and is enforceable against the
Company or such subsidiary, except as limited by bankruptcy, insolvency, reorganization, moratorium
or other similar laws affecting the enforcement of creditors’ rights in general and subject to
general principles of equity (regardless of whether such enforceability is considered in a
proceeding at law or in equity), and (ii) each Material Contract, to the Company’s knowledge, is a
valid, binding and enforceable obligation of the other parties thereto, except as limited by
bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement
of creditors’ rights in general and subject to general principles of equity (regardless of whether
such enforceability is considered in a proceeding at law or in equity).

(c) Except as set forth on Schedule 3.13(c) of the Company Disclosure Schedules, none
of the Company or its subsidiaries and, to the Company’s knowledge, no other party to a Material
Contract is in breach or default in any material respect thereunder.

3.14 Absence of Certain Changes.

3.14.1 Since December 31, 2008 through the date hereof, there has not occurred any change,
event or circumstance that has had or would be reasonably expected to have a Material Adverse
Effect.

3.14.2 Except as expressly contemplated by this Agreement or the Ancillary Agreements, since
December 31, 2008 through the date hereof, the Company and its subsidiaries have conducted their
business in the ordinary course generally consistent with past practice in all material respects,
and except as expressly contemplated by this Agreement or the Ancillary Agreements, since December
31, 2008 through the date hereof, none of the Company or any of its subsidiaries has:

(a) except as set forth on Schedule 3.14.2(a) of the Company Disclosure Schedules,
amended its Charter, By-Laws or similar organizational documents;

(b) adopted a plan or agreement of liquidation, dissolution, restructuring, merger,
consolidation, recapitalization or other reorganization;

(c) (i) issued, sold, transferred or otherwise disposed of any shares of its capital stock,
Voting Debt or other voting securities or any securities convertible into or exchangeable for any
of the foregoing, (ii) granted or issued any options, warrants, securities or rights that are
linked to the value of the Common Stock, or other rights to purchase or obtain any shares of its
capital stock or any of the foregoing or any “phantom” stock, “phantom” stock rights, stock
appreciation rights or stock-based performance units, (iii) split, combined, subdivided or
reclassified any shares of its capital stock, (iv) declared, set aside or paid any dividend or
other distribution with respect to any shares of its capital stock, or (v) redeemed, purchased or
otherwise acquired any shares of its capital stock or any rights, warrants or options to acquire
any such shares or effected any reduction in capital, except (with respect to clauses (i) through
(v) above): (A) for issuances of securities of the Company’s subsidiaries and the Joint Ventures
and their subsidiaries to the Company or a wholly owned subsidiary of the

 

23

 

 Company, (B) for dividends or other distributions by any subsidiary of the Company or any
Joint Venture or subsidiary thereof to the Company or a wholly owned subsidiary of the Company; (C)
in connection with grants made pursuant to, and in accordance with all of the terms and provisions
of, the Plans and Benefit Arrangements in the ordinary course of business; (D) (solely with respect
to clause (i)) Permitted Encumbrances; and (E) as otherwise set forth on Schedule 3.14.2(c)
of the Company Disclosure Schedules;

(d) except as set forth on Schedule 3.14.2(d) of the Company Disclosure Schedules,
entered into or consummated any transaction involving the acquisition (including, by merger,
consolidation or acquisition of the business, stock or all or substantially all of the assets or
other business combination) of any other person for consideration in excess of $5,000,000;

(e) except as set forth on Schedule 3.14.2(e) of the Company Disclosure Schedules,
settled any Action involving a payment by the Company or any of its subsidiaries in excess of
$1,000,000;

(f) changed any of its material accounting policies or practices, except as a result of a
change in GAAP or the rules and regulations of the SEC;

(g) (i) made, changed or revoked any material election in respect of Taxes, (ii) adopted or
changed any material accounting method in respect of Taxes, or (iii) entered into any Tax
allocation agreement, Tax-sharing agreement, Tax indemnity agreement or closing agreement;

(h) except as set forth on Schedule 3.14.2(h) of the Company Disclosure Schedules,
agreed or committed by Contract or otherwise to do any of the foregoing.

3.15 Insurance. Each of the Company and its material subsidiaries maintains, with reputable
insurers or through self-insurance, insurance in such amounts, including deductible arrangements,
and of such a character as is customary for companies engaged in the same or similar business. All
policies of title, fire, liability, casualty, business interruption, workers’ compensation and
other forms of insurance including directors and officers insurance held by the Company and its
subsidiaries as of the date hereof, are in full force and effect in accordance with their terms.
Neither the Company nor any of its subsidiaries is in default under any provisions of any such
policy of insurance and neither the Company nor any of its subsidiaries has received notice of
cancellation of any such insurance, except as has not had and would not reasonably be expected to
have a Material Adverse Effect.

3.16 Private Placement.

(a) Assuming that the representations of the Investors set forth in Section 4.3 are
true and correct, the offer, sale, and issuance of the Investor Securities and the issuance of the
Underlying Shares upon exercise of the Warrants, in each case in conformity with the terms of this
Agreement, are exempt from the registration requirements of Section 5 of the Securities Act.

 

24

 

(b) Assuming that the representations set forth in Section 4.3 are true and correct
with respect to Yucaipa Manager as though made by Yucaipa Manager with respect to the REF Warrants,
the offer, sale and issuance of the REF Warrants and the issuance of the REF Underlying Shares upon
exercise of the REF Warrants, in each case in conformity with the terms of the Real Estate Fund
Formation Agreement, are exempt from the registration requirements of Section 5 of the Securities
Act.

3.17 Form S-3 Eligibility. The Company meets the eligibility requirements of General
Instruction I to Form S-3 promulgated under the Securities Act.

3.18 Brokers. Except as disclosed on Schedule 3.18 of the Company Disclosure
Schedules, the Company and its subsidiaries have incurred no obligation or liability, contingent or
otherwise, in connection with this Agreement that would result in the obligation of the Investors
to pay any finder’s fees, brokerage or agent’s commissions or other like payments in connection
with the negotiations leading to this Agreement or the consummation of the transactions
contemplated hereby.

3.19 Listing and Maintenance Requirements. The Company has not since February 17, 2006
received notice (written or oral) from Nasdaq to the effect that the Company is not in compliance
with the listing or maintenance requirements of Nasdaq. The Company is, and has since such date
been, in compliance in all material respects with all such listing and maintenance requirements.
The Company has not applied for and been denied the right to list any of its securities on any
stock exchange or automated quotation system.

3.20 Registration Rights. Except as set forth in the SEC Reports and pursuant to the
Registration Rights Agreement, the Company has not granted or agreed to grant, and is not under any
obligation to provide, any rights (including “piggy-back” registration rights) to register under
the Securities Act any of its presently outstanding securities or any of its securities that may be
issued subsequently.

3.21 No Restriction on the Ability to Pay Cash Dividends. Except as disclosed in Schedule
3.21 of the Company Disclosure Schedules, neither the Company nor the Operating Company is a
party to any Contract, and is not subject to any provisions in its Charter or By-Laws or other
governing documents or resolutions of the Board of Directors or other governing body, that
restricts, limits, prohibits or prevents the payment of cash dividends with respect to any of its
equity securities.

3.22 Joint Ventures. Except as set forth in Schedule 3.22 of the Company Disclosure
Schedules:

(a) Neither the Company nor any subsidiary of the Company (i) has any funding or capital
contribution obligations with respect to any Joint Venture (excluding any obligations to indemnify
a Joint Venture or another party to a Joint Venture for a breach of the operating agreement (or
equivalent governing document) of such Joint Venture), or (ii) is actually or contingently liable
in respect of any Indebtedness or any other obligations of any Joint Venture.

 

25

 

(b) Neither the Company nor any subsidiary of the Company has scheduled funding obligations or
capital contribution obligations in excess of $5,000,000 with respect to any Joint Venture.

(c) Schedule 3.22 of the Company Disclosure Schedules includes a complete and accurate
list of all Guarantees and other guarantees, e.g., equity maintenance agreements, performance
guarantees and completion guarantees, provided by the Company or any subsidiary of the Company in
respect of any Indebtedness or other obligations of any Joint Venture (the “JV
Guarantees”). True and correct copies of all JV Guarantees have been provided to the
Investors, and no JV Guarantee has been modified, supplemented or altered in any respect from the
form provided to the Investors.

(d) The execution, delivery and performance by the Company of this Agreement and the Ancillary
Agreements do not, and the consummation of the transactions contemplated hereby and thereby and
compliance with the provisions hereof and thereof will not: (1) result in a “change of control” (or
similar event) under, or conflict with, or result in any default under, or give rise to an increase
in, or right of termination, cancellation, acceleration or mandatory prepayment of, any obligation
or to the loss of a benefit under, or result in the suspension, revocation, impairment, forfeiture
or amendment of any term or provision of or the creation of any Encumbrance upon any of the
properties or assets of the Company, any of its subsidiaries or any Joint Venture under, or require
any consent or waiver under, any JV Guarantee or other Contract of the Company or any of its
subsidiaries relating to a Joint Venture, except to the extent that it does not cause an
acceleration of the obligations under such JV Guarantee or other Contract or result in the Company
or any of its subsidiaries becoming liable thereunder; (2) alter in any respect any funding or
other payment obligations of the Company or any of its subsidiaries with respect to any of the
Joint Ventures, or (3) result in any beneficiary of any JV Guarantee or any holder or obligee of
any Indebtedness or other obligations of any Joint Venture having any recourse or other right of
action with respect thereto against the Company or any of its subsidiaries or any of their
respective assets.

ARTICLE 4

Representations and Warranties of the Investors

Each Investor, severally but not jointly, hereby represents and warrants to the Company, as of
the date of this Agreement, as follows:

4.1 Entity Status. Such Investor is duly incorporated or otherwise organized, validly
existing and in good standing under the Applicable Laws of its governing jurisdiction and has all
requisite corporate or other power and authority to carry on its business as it is now being
conducted, and no proceeding has been instituted in any such jurisdiction revoking, limiting or
curtailing, or seeking to revoke, limit or curtail, such power, authority or qualification.

4.2 Authorization; Noncontravention.  

(a) Authorization. Such Investor has all necessary entity power and authority to
execute and deliver this Agreement and the Ancillary Agreements

 

26

 

 

to which it is a party, to perform its obligations hereunder and thereunder and to consummate
the transactions contemplated hereby and thereby. The execution, delivery and performance of this
Agreement and the Ancillary Agreements to which it is a party and the consummation by such Investor
of the transactions contemplated hereby and thereby have been duly and validly authorized by all
necessary entity action, and no other entity proceedings on the part of such Investor or vote of
holders of any class or series of capital stock or equity interests of such Investor is necessary
to authorize this Agreement and the Ancillary Agreements to which such Investor is a party or to
consummate the transactions contemplated hereby or thereby. This Agreement and the Ancillary
Agreements to which such Investor is a party have been duly executed and delivered by such Investor
and (assuming due authorization, execution and delivery by the Company) each constitutes a valid
and binding obligation of such Investor, enforceable against such Investor in accordance with its
respective terms, except as enforceability may be limited by bankruptcy, insolvency,
reorganization, moratorium and other similar laws relating to or affecting creditors’ rights
generally or by general equitable principles (regardless of whether such enforceability is
considered in a proceeding in equity or at law).

(b) No Conflict. Such Investor is not in violation or default of any provision of its
organizational documents. The execution, delivery and performance by such Investor of this
Agreement and the Ancillary Agreements to which it is a party do not, and the consummation of the
transactions contemplated hereby and thereby and compliance with the provisions of this Agreement
and the Ancillary Agreements to which it is a party will not, conflict with, or result in any
default under, any provision of (i) the organizational documents of such Investor, (ii) any
material Contract to which such Investors is a party or by which any of such Investor’s assets are
bound, or (iii) any Applicable Law, Governmental Authorization or Judgment, in each case applicable
to such Investor, other than, in the case of clauses (ii) and (iii), any such conflicts or defaults
that would not reasonably be expected to materially impair or delay the ability of such Investor to
perform its obligations under this Agreement or the Ancillary Agreements to which it is a party or
carry out the transactions contemplated hereby or thereby in accordance with the terms hereof or
thereof. No Governmental Authorization, order or authorization of, or registration, qualification,
declaration or filing with, or notice to, any Governmental Entity is required to be obtained or
made by or with respect to such Investor in connection with the execution, delivery and performance
of this Agreement or any of the Ancillary Agreements to which such Investor is a party or the other
transactions contemplated by this Agreement or the Ancillary Agreements, except for such
Governmental Authorizations, orders, authorizations, registrations, declarations, filings and
notices, the failure of which to be obtained or made would not materially impair such Investor’s
ability to perform its obligations under this Agreement or the Ancillary Agreements or consummate
the transactions contemplated hereby or thereby.

4.3 Securities Act; Purchase for Investment Purposes. Such Investor (i) is acquiring the
Investor Securities solely for investment with no present intention to distribute them in violation
of the Securities Act and the rules and regulations thereunder or any applicable U.S. state
securities laws, (ii) has such knowledge and experience in financial and business matters and in
investments of this type that it is capable of evaluating the merits and risks of making an
informed investment decision to purchase the Investor Securities, and (iii) is an “institutional
accredited investor” (as that term is

 

27

 

defined by Rule 501 promulgated under the Securities Act). Such Investor understands that the
purchase of the Investor Securities involves substantial risk. Such Investor did not learn of the
opportunity to purchase the Investor Securities by means of any form of general or public
solicitation or general advertising, or publicly disseminated advertisements or sales literature,
including (i) any advertisement, article, notice or other communication published in any newspaper,
magazine, or similar media, or broadcast over television or radio, or (ii) any seminar or meeting
to which the Investor was invited by any of the foregoing means of communications. Such Investor
understands that the Investor Securities will be characterized as “restricted securities” under the
United States federal securities laws inasmuch as they are being acquired from the Company in a
transaction not involving a public offering and that under such laws and applicable regulations
such securities may be resold without registration under the Securities Act only in certain limited
circumstances. Such Investor understands that no United States federal or state agency or any
other government or governmental agency has passed on or made any recommendation or endorsement of
the shares or the fairness or suitability of the Investor Securities. Such Investor understands
that until such time as the resale thereof has been registered under the Securities Act,
certificates evidencing the Investor Securities shall bear the following legend:

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES
LAWS. NEITHER THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR ANY INTEREST OR
PARTICIPATION HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED,
ENCUMBERED, OR OTHERWISE DISPOSED OF IN ABSENCE OF SUCH REGISTRATION OR UNLESS
SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, REGISTRATION UNDER THE
SECURITIES ACT.

4.4 Brokers. Such Investor has incurred no obligation or liability, contingent or otherwise,
in connection with this Agreement that would result in the obligation of the Company or any of its
Affiliates to pay any finder’s fees, brokerage or agent’s commissions or other like payments in
connection with the negotiations leading to this Agreement or the consummation of the transactions
contemplated hereby.

4.5 Available Funds. Such Investor has sufficient funds in its possession to permit it to pay
its portion of the Investment Amount.

ARTICLE 5

Covenants

5.1 Further Assurances. The Company, on the one hand, and the Investors, on the other hand,
shall use their commercially reasonable efforts to do and perform, or cause to be done and
performed, all such further acts and things and shall execute and deliver all such other
agreements, certificates, instruments or documents as the other may reasonably request in order to
carry out the intent and purposes of this Agreement and the consummation of the transactions
contemplated hereby.

 

28

 

5.2 Fees and Expenses; Commitment Fee.

(a) Upon an Investor’s request from time to time (including on the date hereof as contemplated
by Section 2.2.1(d)), the Company shall promptly pay or reimburse, or cause to be paid or
reimbursed, all reasonable out-of-pocket costs and expenses incurred by such Investor or on such
Investor’s behalf in connection with this Agreement and the Ancillary Agreements (including
reasonable fees and expenses of accountants and legal counsel of the Investors); provided,
that the aggregate amount paid or reimbursed by the Company in respect of such costs and expenses
incurred by the Investors or on the Investors’ behalf shall in no event exceed $600,000 in the
aggregate for the Investors.

(b) In connection with the purchase of the Investor Securities hereunder, on the date hereof,
the Company shall pay to Yucaipa American Funds, LLC, an Affiliate of the Investors, a commitment
fee of $2,437,500.

5.3 Stockholder Approvals. The Company shall use its commercially reasonable efforts to
present and recommend to the stockholders of the Company at a special meeting of the stockholders
of the Company (to be held in accordance with the corporate laws of Delaware, the Charter and the
By-Laws), duly noticed and called for not later than January 15, 2010, a proposal to approve the
terms of the Warrants and the REF Warrants, the full exercise of the Warrants and the REF Warrants
and the issuance of the Underlying Shares and REF Underlying Shares as Common Stock in connection
therewith. If such approval is not obtained at a meeting of stockholders of the Company on or
prior to January 15, 2010, the Company shall not thereafter have any obligation to continue to try
to obtain such approval.

5.4 Rights Plan. Except with the express prior written consent of YAAF II, on behalf of the
Investors (which consent may be withheld in YAAF II’s sole discretion as to clause (a) below, but
shall not be unreasonably withheld as to clause (b) below), the Company shall not, and shall cause
its subsidiaries not to, enter into any modification, amendment, supplement or other alteration of
the Rights Plan, or adopt any successor “stockholder rights plan,” “poison pill,” or other
comparable plan or arrangement, that (a) would result in the Investors, Yucaipa Manager or any of
them or their respective Affiliates becoming an “acquiring person” as defined in the Rights Plan or
having a similar effect under the Rights Plan as it may be amended or under any comparable plan or
arrangement that may be adopted in the future, or (b) would limit the Investors’ or any of their
respective Affiliates’ ability to acquire, hold or dispose of any securities of the Company in a
manner that is more restrictive or limiting in any respect than would be the case under the Rights
Plan, as modified by the Rights Plan Amendment and otherwise as in effect on the date hereof, it
being understood that the following shall not in any event require the consent of YAAF II on behalf
of the Investors: (i) an extension of the expiration date of the Rights Plan, as modified by the
Rights Plan Amendment and otherwise as in effect on the date hereof, and (ii) any modification,
amendment, supplement or other alteration of the Rights Plan (as modified by the Rights Plan
Amendment and otherwise as in effect on the date hereof) or any adoption of any successor
“stockholder rights plan,” “poison pill,” or any other comparable plan or arrangement that provides
that such modifications, changes or other alterations to the Rights Plan (as modified by the Rights
Plan Amendment and otherwise as in effect on the

 

29

 

date hereof) are not applicable to the Investors or any of their respective Affiliates. Upon
written request by a Yucaipa Holder (as such term is defined in the Rights Plan) from time to time,
the Company shall promptly furnish such Yucaipa Holder with the number of issued and outstanding
shares of Common Stock as of a recent date for purposes of determining Beneficial Ownership (as
such term is defined in the Rights Plan) by such Yucaipa Holder.

5.5 Gaming and Liquor Licenses. The Company shall, and shall cause its officers and employees
to, cooperate in good faith (such cooperation to be provided at the Company’s sole cost and
expense) in connection with any efforts by the Investors or their Affiliates to obtain any
Governmental Authorization under Gaming Laws or laws regulating the sale of alcoholic beverages,
including by providing copies of documents in the possession of the Company or its Affiliates,
attending meetings and proceedings, and consulting and cooperating with the Investors and their
Affiliates in connection with the preparation of any written submissions to and/or proceedings
before Gaming Authorities. The Investors shall pay their own costs and expenses in connection with
any such Governmental Authorizations.

5.6 Certain Approval Rights.

(a) For so long as the Investors collectively own, or have the right to purchase through
exercise of the Warrants (whether or not any or all of such Warrants are exercisable), an aggregate
of at least 6,250,000 shares of Common Stock (subject to adjustment in accordance with Section
7.14), the Company shall not, directly or indirectly, take any of the following actions,
including the entry into any contract, agreement, arrangement or transaction (or series of related
contracts, agreements, arrangements or transactions) with respect to any of the following actions,
without the prior written approval of each Investor (which approval may be withheld in the
Investors’ sole discretion as to clauses (i), (iii) and (iv) below but shall not be unreasonably
withheld as to clause (ii) below):

(i) sell or transfer all or substantially all of the assets of the Company and its
subsidiaries, taken as a whole, to any Third Party;

(ii) any transaction involving the acquisition (including by merger, consolidation, other
business combination, or acquisition of all or substantially all of the capital stock or assets of
any Third Party) of any Third Party by the Company or any of its subsidiaries where the equity
investment by the Company and its subsidiaries is $100,000,000 or greater;

(iii) any transaction involving the acquisition (including by merger, consolidation, other
business combination, or acquisition of all or substantially all of the assets of the Company and
its subsidiaries, taken as a whole, other than an acquisition that is an acquisition of
substantially all of the assets of the Company and its subsidiaries, taken as a whole, as the
result of the disposition by the Company or its subsidiaries of real estate assets where the
Company and its subsidiaries, taken as a whole, will continue to engage in the business of managing
hotel properties and other real property assets) of the Company by any Third Party; or

 

30

 

(iv) any change in the size of the Board of Directors to a number below 7 or above 9;
provided, that if an Investor Nominee shall fail to be elected to the Board of Directors
and the Board of Directors shall increase the size thereof by a single director (not to exceed 11
total directors) and shall fill the vacancy created thereby with the Investor Nominee, then the
Investors shall not have an approval right pursuant to this Section 5.6(a)(iv) over such
increase.

Notwithstanding the foregoing, the prior written approval of the Investors shall not be
required prior to the Company taking any action described in the foregoing Sections 5.6(a)(i) or
5.6(a)(iii) (a “Designated Transaction”) if (A) such Designated Transaction has been
approved by the Board of Directors by a vote of at least 75% of the directors of the Company
(excluding any director who has recused himself or herself from voting on such Designated
Transaction) and (B) the Investors or any of their Affiliates have (directly or indirectly,
individually or in concert with another person or as part of a “group” (as defined in Section 13 of
the Exchange Act)) taken an action described in Section 5.13(a) within the six-month period prior
to the applicable date of determination (an “Investor Proposal”).

(b) Prior to the Board of Directors considering a Designated Transaction, the Company shall
give the Investors written notice thereof (including the intended time for the Board of Directors’
consideration thereof) concurrently with notice of the same to members of the Board of Directors
and shall provide the Investors with all written materials provided to the directors regarding the
same (except to the extent that providing such materials would reasonably likely adversely affect
the attorney-client privilege between the Company and its counsel or is expressly prohibited by the
investment bankers or other advisers providing such materials) subject to customary confidentiality
restrictions concurrently when providing such materials to the members of the Board of Directors.
In the event that the Board of Directors approves any Designated Transaction as to which the
Investors or their Affiliates have made an Investor Proposal by a vote of less than 75% of the
directors of the Company (excluding any director who has been recused from the consideration of
such Designated Transaction), the Company shall furnish written notice of such approval to the
Investors (the “Designated Transaction Notice”). Each Investor shall then notify the
Company in writing whether it approves or rejects the Designated Transaction that is the subject of
such Designated Transaction Notice as soon as reasonably practicable, and in no event later than
the earlier of (A) 24 hours after receipt of such Designated Transaction Notice, and (B) the next
opening of trading in the Company’s Common Stock on the first Business Day following receipt of
such Designated Transaction Notice that is not less than 12 hours after receipt of such Designated
Transaction Notice.

5.7 Board Representation.

(a) The Company represents and warrants to the Investors that:

(i) Each of the directors of the Company identified in the secretary’s certificate delivered
do the Investors pursuant to Section 2.2.1(c)(i) (or in the applicable annex thereto) has
resigned from the Board of Directors effective as of the date hereof (the “Resignations”),
by means of delivering written notice of his or her resignation to the Board of Directors in
accordance with Section 2.2 of the By-Laws. A

 

31

 

 

true and correct copy of each Resignation notice has been provided to the Investors as an
annex to such secretary’s certificate. Each Resignation has been accepted by the Board of
Directors on behalf of the Company and is in full force and effect.

(ii) The Appointment Resolutions in the form annexed to the secretary’s certificate delivered
to the Investors pursuant to Section 2.2.1(c)(i) are in full force and effect as of the
date hereof and have not been amended, supplemented, revoked or superseded, and there are no other
resolutions of the Board of Directors concerning the subject matter thereof.

(b) (i) The parties acknowledge and agree that it is their intent that the Investors shall
have the right to appoint one person to the Board of Directors (the “Investor Nominee”) for
so long as the Investors collectively own, or have the right to purchase through exercise of the
Warrants (whether or not any or all of such Warrants are exercisable and assuming a cash exercise
of such Warrants), an aggregate of at least 875,000 shares of Common Stock (subject to adjustment
in accordance with Section 7.14) (the “Common Stock Board Condition”). The parties
further acknowledge and agree that the initial Investor Nominee was elected to the Board of
Directors pursuant to the Appointment Resolutions and that such person shall continue to be the
Investor Nominee unless and until such person is replaced pursuant to Section
5.7(b)(ii)(2).

(ii) At any time that the Common Stock Board Condition is satisfied:

	 	(1)	 	The Company shall use its reasonable best efforts to cause
the Board of Directors (or the appropriate committee thereof) to nominate and
recommend to the stockholders of the Company the election of the Investor
Nominee at any meeting of the stockholders of the Company (or in any
resolution by written consent in lieu thereof) at which the Investor Nominee
is being considered for election to the Board of Directors, and use its
reasonable best efforts to ensure that the Investor Nominee is elected to the
Board of Directors at each such meeting (or in each such resolution by written
consent in lieu thereof);

	 	(2)	 	YAAF II, on behalf of the Investors, by delivery of written
notice to the Company at any time or from time to time, shall have the right,
in its sole and absolute discretion, to direct that an Investor Nominee then
serving as a director of the Company (or as an observer of the Board of
Directors) be removed from the Board of Directors (or as an observer thereof),
and/or that any Investor Nominee be replaced with a replacement Investor
Nominee named in such notice; provided, that, any such replacement
Investor Nominee shall be reasonably satisfactory in accordance with the
applicable selection criteria for directors of the Company from time to time
set forth in the Company’s “Corporate Governance Guidelines”. For the
avoidance of doubt, the Investor Nominee need not be “independent” of the
Company for purposes of the Rules or any Company policies or guidelines. In
the event that

 

32

 

	 	 	 	
 YAAF II, on behalf of the Investors, notifies the Company in writing that
it desires to remove and/or replace an Investor Nominee in accordance with
this Section 5.7(b)(ii)(2), then the Company shall use its
reasonable best efforts to cause the Board of Directors and stockholders
of the Company, as applicable, to comply with such request as promptly as
practicable, and such replacement Investor Nominee shall continue to be
the “Investor Nominee” hereunder unless and until such person is replaced
by YAAF II, on behalf of the Investors, pursuant to this Section
5.7(b)(ii)(2);

	 	(3)	 	In the event that an Investor Nominee is not elected to the
Board of Directors at any meeting of stockholders at which directors are
elected, if the Company notifies the Investors that there is an available seat
on the Board of Directors (due to increasing the size of the Board of
Directors, filling a vacancy or otherwise), YAAF II, on behalf of the
Investors, by delivery of written notice to the Company, shall promptly select
a replacement Investor Nominee. Such replacement Investor Nominee shall be
reasonably satisfactory in accordance with the applicable selection criteria
for directors of the Company from time to time set forth in the Company’s
“Corporate Governance Guidelines”. For the avoidance of doubt, the Investor
Nominee need not be “independent” of the Company for purposes of the Rules or
any Company policies or guidelines. In such event, the Company shall use its
reasonable best efforts to cause the Board of Directors to comply with such
request as promptly as practicable, and such replacement Investor Nominee
shall continue to be the “Investor Nominee” hereunder unless and until such
person is replaced by YAAF II, on behalf of the Investors, pursuant to this
Section 5.7(b)(ii)(2); and

	 	(4)	 	Unless and until the Investor Nominee is elected to the Board
of Directors (and during any period of time that the Investor Nominee is not
serving as a director of the Board of Directors), the Company shall invite the
Investor Nominee, and the Investor Nominee shall have the right, to attend all
meetings of its Board of Directors in a nonvoting observer capacity and, in
this respect, shall give such Investor Nominee copies of all notices, minutes,
consents and other material that it provides to its directors; provided that
the Company reserves the right to withhold any information and to exclude such
Investor Nominee from any meeting or portion thereof if a conflict of interest
exists, if the Board of Directors plans to discuss a matter involving the
Company or its subsidiaries, on the one hand, and an Affiliate of one of the
Investors, on the other hand, or if access to such information or attendance
at such meeting would reasonably likely adversely affect the attorney-client
privilege between the Company

 

33

 

	 	 	 	

and its counsel or result in the disclosure of trade secrets. The
Investor Nominee shall agree to customary confidentiality restrictions.

5.8 Publicity. The Company and the Investors shall communicate with each other and cooperate
with each other prior to any public disclosure of the purchase and sale of the Investor Securities.
The Company, on the one hand, and the Investors, on the other hand, agree that no public release
or announcement concerning the purchase and sale of the Investor Securities shall be issued by or
as a result of the actions of any of them without the prior consent of the other, which consent
shall not be unreasonably withheld or delayed, except as such release or announcement may be
required by Applicable Law or the rules and regulations of Nasdaq, in which case the party required
to make the release or announcement shall use its reasonable best efforts to consult with the other
parties hereto about, and allow the other parties hereto to reasonably comment on, such release or
announcement in advance of such issuance.

5.9 Hedging. On and after April 15, 2011, the Investors shall be permitted to enter into any
short sale, swap, hedge, forward contract, credit default swap, or any other agreement, transaction
or series of transactions that hedges or transfers, in whole or in part, directly or indirectly,
any of the economic consequences of ownership of any Investor Securities, whether any such
transaction, swap or series of transactions is to be settled by delivery of securities, in cash or
otherwise (each, a “Hedging Transaction”), and prior to such date, the Investors and their
Affiliates shall not enter into any Hedging Transaction or any other transaction which reasonably
could be expected to lead to or result in a sale or disposition of any Investor Securities or
Common Stock even if such shares would be disposed of by someone other than an Investor or its
Affiliate. The Company acknowledges that from and after April 15, 2011, subject to compliance with
applicable securities laws and the Company’s insider trading policies as in effect from time to
time (it being agreed by the Company that it will not revise its insider trading policies to
prevent or limit in a material respect Hedging Transactions beyond any limitations in place on the
date hereof), there shall be no restriction under this Agreement on the Investors’ ability to enter
into any Hedging Transaction or otherwise hedge any securities of the Company or take any of the
other actions described in the previous sentence.

5.10 Investor Right of First Refusal.

(a) Until the first anniversary of the date hereof, each Investor shall have the right to
purchase its Pro Rata Amount of any New Securities that the Company may, from time to time, propose
to sell and issue. In the event that the Company proposes to issue any New Securities prior to
such first anniversary of the date hereof, it shall give the Investors written notice at least 10
Business Days before such issuance, describing in reasonable detail the type of New Securities, the
price and number of shares (or principal amount) to be issued, and the general terms upon which the
Company proposes to issue such New Securities. Each such notice shall constitute an irrevocable
offer by the Company to each Investor to purchase up to the amount of New Securities equal to its
Pro Rata Amount of

 

34

 

such New Securities (subject to increase as set forth in the immediately
following sentence) upon the terms reflected in such notice. Each Investor shall have 10 Business
Days from the date of receipt of such notice to agree to purchase up to the amount of New
Securities equal to its Pro Rata Amount of such New Securities (and any New Securities offered to another Investor if such other Investor
does not elect to purchase its full Pro Rata Amount of New Securities) by giving written notice to
the Company of its intention to purchase such New Securities at the closing of the sale of New
Securities and the number of such New Securities that it intends to purchase; provided,
that, with respect to an underwritten public offering by the Company of its New Securities in which
(i) the Company has provided each Investor written notice thereof pursuant to this Section 5.10(a),
(ii) the Company has concurrently provided to the Investors all material information relating to
such offering that has been provided to potential investors in the New Securities, and (iii) the
Company has kept the Investors apprised of the estimated timing and pricing for such offering in a
commercially reasonable manner during such offering process (including at least 48 hours notice of
the proposed time of pricing and the estimated pricing range or pricing formula), the Investors
shall be permitted to accept such offer until the latest time that other investors are permitted to
commit to participate in such offering, after which such offer shall lapse. An Investor electing
to exercise its right to purchase New Securities pursuant to this Section 5.10 may make any
such election contingent upon obtaining any Governmental Authorizations required in connection with
such purchase, including any such Governmental Authorizations pursuant to Gaming Laws or pursuant
to the HSR Act.

(b) If and to the extent that any Investor fails to exercise in full its right to purchase New
Securities within the periods required for such exercise, then the Company shall have 60 days
thereafter to sell the New Securities with respect to which the Investors did not exercise their
rights to purchase upon terms no less favorable to the Company (taken as a whole) than the terms
reflected in the notice by which such New Securities were offered to the Investors. The Company
shall not issue or sell any additional amounts of New Securities after the expiration of such
60-day period without first offering such securities to the Investors in the manner provided in
this Section 5.10.

5.11 VCOC. The Company shall, on the date hereof, enter into a management rights letter with
each of the Investors (and, at the request of an Investor, an Affiliate of such Investor) in the
forms of Exhibit I attached hereto and, at each Investor’s request from time to time
thereafter, enter into such amended or replacement customary management rights letter in such form
and substance as each Investor reasonably determines is required in order for such Investor to
maintain its status, or the status of any of its Affiliates, as a “venture capital operating
company” for purposes of ERISA.

5.12 Certain Tax Matters.

(a) The Company and the Investors acknowledge and agree that the Investor Securities are being
issued solely in consideration of the Investment Amount and neither the Company nor the Investors
shall take any position for financial accounting, Tax or other purposes inconsistent with such
agreement. Without limiting the foregoing, the Company shall not record an expense or apply any
withholding (other than any withholding that may be required by law pursuant to Section 1441, 1442
or 1445 of the Code) in connection with the issuance or any exercise or redemption of, any
adjustment to, or any payments made in respect of any of the Investor Securities.

 

35

 

(b) The Company and the Investors acknowledge and agree that, if it is determined that the
Preferred Securities are properly treated as more likely than not to be redeemed within the meaning
of Treasury Regulations Section 1.305-5(b)(3), the Company shall not take the position that the
time that redemption is most likely to occur is any earlier than the seventh anniversary of the
Original Issue Date (as such term is defined in the Certificate of Designations).

(c) Upon the request of the Investors from time to time, but no more often than once per
calendar year, the Company shall provide the Investors with such factual information and material
that the Investors reasonably require to determine whether the Company is a United States real
property holding company within the meaning of Section 897 of the Code, provided,
however, that if the preparation of such information and material involves material
third-party expenses, then the Company shall only be required to provide such information to
Investors that agree to bear such third-party expenses.

5.13 Standstill Agreement.

(a) Each Investor agrees that, without the prior approval of the Company, such Investor will
not, directly or indirectly, through its Affiliates or associates or any other persons, or in
concert with any person, or as a participant in a “group” (such term being used in this Section
5.13 as defined in Section 13 of the Exchange Act):

(i) purchase, offer to purchase, hold or agree to purchase or otherwise acquire “beneficial
ownership” (such term being used in this Section 5.13 as defined in the Rights Plan as in
effect as of the date hereof) of any Common Stock, or securities convertible into or exchangeable
for Common Stock, that would result in the Investors and their subsidiaries and Affiliates having
beneficial ownership of more than 39.9% of the outstanding shares of voting stock or Common Stock
of the Company (treating warrants and exchangeable or convertible securities of the Company that
are beneficially owned by a person or its Affiliates as fully converted into Common Stock),
provided, that to the extent that the Investors and their subsidiaries and Affiliates hold
beneficial ownership of more than 39.9% of the outstanding shares of voting stock or Common Stock
of the Company (treating warrants and exchangeable or convertible securities of the Company that
are beneficially owned by a person or its Affiliates as fully converted into Common Stock) as a
result of repurchases of shares of Common Stock by the Company, the Investors and their
subsidiaries and Affiliates shall not be required to dispose of shares of voting stock or Common
Stock in order to hold beneficial ownership of 39.9% or less of the outstanding shares of voting
stock or Common Stock of the Company (treating warrants and exchangeable or convertible securities
of the Company that are beneficially owned by a person or its Affiliates as fully converted into
Common Stock) unless and to the extent that such holding in excess of 39.9% would result in a
default or loan repayment obligation by the Company or an Affiliate of the Company of any Material
Indebtedness of the Company or its subsidiaries or would trigger a change of control provision
under a material Contract of the Company or any of its subsidiaries;

(ii) make, or in any way participate in, any solicitation of proxies to vote any voting
securities of Company or any of its subsidiaries, or seek to

 

36

 

control or direct the management of the Company or the Board of Directors by way of any public
communication, or communication with any person other than the Company or its authorized
representatives;

(iii) make any public announcement with respect to, or submit a proposal for, or offer of
(with or without conditions) any acquisition of, or extraordinary transaction involving, the
Company or any of Company’s subsidiaries or any of their respective securities or assets; or

(iv) enter into any negotiations, arrangements or understandings with, or form, join or
participate in a group with, any other person in such other person’s taking, planning to take, or
seeking to take any of the actions described in clauses (i) through (iii) of this Section 5.13(a)
or otherwise act, alone or in concert with others, to seek to control or direct the management of
the Company or the Board of Directors.

(b) Notwithstanding anything to the contrary contained herein, (1) this Section 5.13
shall not prohibit or otherwise limit any actions by any member of the Board of Directors
(including any Affiliate of an Investor or any person appointed or otherwise designated to the
Board of Directors by any of the Investors) in connection with the exercise of his or her duties as
a member of the Board of Directors; and (2) subject to clause (c) immediately below, if (A) any
person or “group” (excluding the Investors and their Affiliates) files a Form 13D disclosing the
acquisition of 15% or more of the Common Stock and such event has not been endorsed or supported by
the Board of Directors within 10 Business Days of the occurrence of such event, (B) any person or
“group” (excluding the Investors and their Affiliates) commences one or more solicitations of
proxies seeking to remove and/or appoint members of the Board of Directors which if successful
would result in such person or “group” (without duplication) having removed, having appointed or
being affiliated or associated with an aggregate of three or more such members who are or would
serve concurrently, or (C) any person or “group” (excluding the Investors and their Affiliates)
provides written notice to the Board of Directors of, or publicly announces, a bona fide intention
to engage in any of the actions described in the foregoing clauses (A) and (B), then the Investors
shall be permitted at their sole option to make a confidential proposal to the disinterested
members of the Board of Directors with respect to a transaction described in Section
5.13(a) above; provided, however, that with respect to foregoing clause (B) and
(C), if the applicable proxy solicitation(s) seek the removal of less than a majority of the Board
of Directors in the aggregate, then the Investors shall only be permitted to make a confidential
proposal to the disinterested members of the Board of Directors with respect to a transaction
described in Section 5.13(a)(ii) above only.

(c) If (A) the Company has sought the consent of the Investors pursuant to Section 5.6
with respect to a Designated Transaction, (B) such Designated Transaction was approved by the Board
of Directors, and (C) the Investors have exercised their right to veto such Designated Transaction
pursuant to Section 5.6(a), then no Investor shall be permitted to make a confidential proposal to
the disinterested members of the Board of Directors as permitted pursuant to Section
5.13(b)(2) above prior to the date that is six months following the date on which such veto was
made.

 

37

 

 to control or direct the management of the Company or the Board of Directors by way of any public
communication, or communication with any person other than the Company or its authorized
representatives;

(d) Each Investor’s obligations under this Section 5.13 shall terminate and be of no
further force and effect on the first date that the Investors and their Affiliates have beneficial
ownership (as defined in the Rights Plan as in effect on the date hereof) of less than 15% of the
outstanding Common Stock (treating warrants and exchangeable or convertible securities of the
Company that are beneficially owned by a person or its Affiliates as fully converted into Common
Stock in accordance with their respective terms).

5.14 Company Right of First Refusal. From and after the sixth anniversary of the date hereof:

(a) Subject to the further terms and conditions of this Section 5.14, if an Investor proposes
to sell greater than 1,000,000 shares of Common Stock in a single transaction or series of related
transactions, such Investor shall give the Company prior written notice thereof (the “ROFR
Notice”), including in reasonable detail the price and number of shares of Common Stock to be
sold, and the general terms upon which such Investor proposes to sell such shares. Each such ROFR
Notice shall constitute an irrevocable offer by such Investor to the Company to purchase all (but
not less than all) of the shares of Common Stock included in such notice upon the terms and
conditions reflected in such notice. If a ROFR Notice is delivered to the Company after 1:00 p.m.,
New York City time, on any Business Day, it shall be deemed received on the next succeeding
Business Day.

(b) The Company shall have two Business Days from the date of receipt of a ROFR Notice to
agree to purchase all (but not less than all) of the shares of Common Stock described therein by
delivering written notice (the “Company Notice”) to such Investor of its election to
purchase all of such shares of Common Stock prior to 5:00 p.m. (New York City time) on the second
Business Day following the delivery of the applicable ROFR Notice. The Company shall effect the
purchase of any such shares of Common Stock, including payment of the purchase price, not more than
three Business Days after delivery of the Company Notice.

(c) If and to the extent that the Company fails to exercise its right to purchase all of the
shares of Common Stock described in any ROFR Notice pursuant to the foregoing clause (a) within the
period required for such election, then the Investor shall have 60 days thereafter to sell such
shares of Common Stock on terms no less favorable to the Investor (taken as a whole) than the terms
set forth in the ROFR Notice.

(d) The rights of the Company, and the obligations of the Investors, under this Section 5.14
shall terminate and be of no further force and effect from and after the first date that the
Investors beneficially own (as such term is defined in the Rights Plan as in effect on the date
hereof) less than 10% of outstanding shares of Common Stock (treating warrants and exchangeable or
convertible securities of the Company that are beneficially owned by a person or its Affiliates as
fully converted into Common Stock).

 

38

 

ARTICLE 6

Indemnification

6.1 Indemnification. All representations and warranties contained in this Agreement
shall survive the Closing Date for a period of twenty months except that (i) with respect to claims
asserted pursuant to this ARTICLE 6, such claims shall survive until the date that they are
finally liquidated or otherwise resolved, (ii) the representations and warranties set forth in
Section 3.8 shall survive for the duration of the applicable statute of
limitations, and (iii) the representations and warranties set forth in Sections 3.2,
3.3, 3.18, 4.2 and 4.4 (the “Surviving Representations”)
shall survive indefinitely.

(a) Subject to the limitations set forth in this Section 6.1, the Company hereby
agrees to indemnify, pay and hold each Investor, and each of the respective officers, directors,
employees and affiliates of each Investor, and each of the respective direct and indirect
beneficial owners of each Investor (the “Investor Indemnified Parties”) harmless to the
fullest extent permitted by Applicable Law, from and against any and all Losses which may be
imposed on, incurred by or asserted against such Investor Indemnified Party, in any manner relating
to or arising out of (i) the breach by the Company of any representation or warranty set forth in
this Agreement, or (ii) the breach, non-compliance or non-performance of any covenant, agreement or
obligation of the Company contained in this Agreement (other than a breach, non-compliance or
non-performance of or with Section 5.7(b)(ii)(4) due to a final judicial determination by a
court of competent jurisdiction arising from an Action initiated by a Third Party that such Section
is not enforceable); provided, however, that any claim by any Investor Indemnified
Party under clause (i) above shall be made prior to the date on which the applicable representation
and warranty expires pursuant to this Section 6.1 and that any claim by any Investor Indemnified
Party under clause (ii) above shall be made within six months of the time performance of such
covenant or agreement is contemplated.

(b) Subject to the limitations set forth in this Section 6.1, each Investor severally
but not jointly hereby agrees to indemnify, pay and hold the Company and its officers, directors,
employees and affiliates (the “Company Indemnified Parties”) harmless to the fullest extent
permitted by Applicable Law, from and against any and all Losses which may be imposed on, incurred
by, or asserted against such Company Indemnified Party, in any manner relating to or arising out of
(i) the breach by such Investor of any representation or warranty set forth in this Agreement, or
(ii) the breach, non-compliance or non-performance of any covenant, agreement or obligation of such
Investor contained in this Agreement; provided, however, that any claim by any
Company Indemnified Party under clause (i) above shall be made prior to the date on which the
applicable representation and warranty expires pursuant to this Section 6.1 and that any claim by
any Company Indemnified Party under clause (ii) above shall be made within six months of the time
performance of such covenant or agreement is contemplated.

(c) With respect to any claim by an Investor Indemnified Party for indemnification pursuant to
Section 6.1(a)(i),(A) an Investor Indemnified Party shall only be entitled to
indemnification to the extent that, and shall not be entitled to any indemnification until, the
aggregate of all amounts subject to indemnification exceeds

 

39

 

 $2,000,000 (and then only for the amount by which such Losses exceed that amount), and (B) as
to any particular indemnity claim or series of indemnity claims arising out of the same or related
facts, events or circumstances, an Investor Indemnified Party shall be entitled to seek indemnity
for such claim or claims only if such indemnity claim or series of related indemnity claims equals
or exceeds $150,000, in which case the Investor Indemnified Party shall be entitled to seek
indemnity for the full amount of such claim or claims. Notwithstanding the foregoing: (x) the
maximum liability of the Company for indemnification claims pursuant to Section 6.1(a)(i) except in
the case of a breach of a Surviving Representation shall not exceed $25,000,000, and (y) the
maximum liability of the Company for all indemnification claims pursuant to Section 6.1(a)(i)
(including claims based on breaches of the Surviving Representations) shall not exceed the
Investment Amount. For purposes of determining Losses under this ARTICLE 6, if it is
determined that a breach of a representation and warranty has occurred (giving effect to any stated
limitations for Material Adverse Effect and materiality), then the Investor Indemnified Parties
shall, subject to the immediately preceding sentence, be entitled to indemnification for the full
amount of the Losses arising from such breach without regard to whether and to what extent such
Losses would be considered or qualified by “material” or would constitute or be qualified by
“Material Adverse Effect” (and shall not increase the scope of the matters for which a
representation and warranty is made, including any representations and warranties as to “material
subsidiaries,” “material leases,” “Material Indebtedness” and “Material Contract”).

(d) A party hereto seeking indemnification under this ARTICLE 6 (the “Indemnified
Party”) with respect to any action, lawsuit, proceeding, investigation or other claim brought
against it by a Third Party (a “Third-Party Claim”) shall give prompt written notice to the
party from whom indemnification is sought (the “Indemnitor”) of such Third-Party Claim that
might give rise to indemnified liabilities setting forth a description of those elements of such
Third-Party Claim of which such Indemnified Party has knowledge; provided that any delay or
failure to give such notice shall not affect the obligations of the Indemnitor unless (and then
solely to the extent) such Indemnitor is actually prejudiced by such delay or failure. The
Indemnitor shall have the right at any time during which such Third-Party Claim is pending to
select counsel (which counsel shall be reasonably satisfactory to the Indemnified Party) to defend
and control the defense thereof and settle any Third-Party Claim for which they are responsible for
indemnification hereunder (provided that the Indemnitor will not settle any such
Third-Party Claim without (i) the appropriate Indemnified Party’s prior written consent, which
consent shall not be unreasonably withheld or delayed, or (ii) obtaining an unconditional release
of the appropriate Indemnified Party from all claims arising out of or in any way relating to the
circumstances involving such Third-Party Claim) so long as in any such event the Indemnitor shall
have stated in a writing delivered to the Indemnified Party that, as between the Indemnitor and the
Indemnified Party, the Indemnitor is responsible to the Indemnified Party with respect to such
Third-Party Claim to the extent and subject to the limitations set forth herein; provided,
that if the Indemnitor has reasonably concluded, based on the written advice of counsel, that there
exists or is reasonably likely to exist a conflict of interest that would make it inappropriate for
the same counsel to represent both the Indemnified Party and the Indemnitor, then the Indemnified
Party shall be entitled to retain one separate firm of counsel reasonably acceptable to the
Indemnitor, in which case the reasonable fees,

 

40

 

 disbursements and charges of such counsel will be at the expense of the Indemnitor. The
Indemnified Party shall extend reasonable cooperation in connection with any such defense. All
reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to
the extent incurred in connection with investigating or preparing to defend a matter not
inconsistent with this ARTICLE 6) shall be paid to the Indemnified Party, as incurred, upon
written notice thereof to the Indemnitor (regardless of whether it is ultimately determined that
the Indemnified Party is not entitled to indemnification hereunder; provided that the
Indemnitor may require the Indemnified Party to undertake to reimburse all such fees and expenses
to the extent it is finally determined by a court of competent jurisdiction that the Indemnified
Party is not entitled to indemnification hereunder). To the extent that the undertaking to
indemnify, pay and hold harmless set forth herein may be unenforceable because it is violative of
any Law or public policy, the Indemnitor shall contribute the maximum portion which it is permitted
to pay and satisfy under Applicable Law to the payment and satisfaction of all Indemnified
Liabilities incurred by the Indemnified Parties or any of them.

ARTICLE 7

General Provisions

7.1 Amendments and Waivers. This Agreement may not be amended except by an instrument in
writing signed on behalf of each of the parties hereto. Except as otherwise provided in this
Agreement, any failure of any party to comply with any obligation, covenant, agreement or condition
herein may be waived by the party entitled to the benefits thereof only by a written instrument
signed by the party granting such waiver, but such waiver shall not operate as a waiver of, or
estoppel with respect to, any subsequent or other failure. The failure of any party to this
Agreement to assert any of its rights under this Agreement or otherwise shall not constitute a
waiver of such rights.

7.2 Assignment. This Agreement and the rights and obligations hereunder shall not be
assignable or transferable by any party without the prior written consent of the other parties
hereto. Any attempted assignment in violation of this Section 7.2 shall be void.

7.3 No Third-Party Beneficiaries. This Agreement is for the sole benefit of the parties
hereto and their permitted assigns and nothing herein expressed or implied shall give or be
construed to give to any person, other than the parties hereto and such permitted assigns, any
legal or equitable rights hereunder, except that (a) each Indemnified Party is an intended
beneficiary of Section 6.1 and may enforce the provisions of such Section directly against
the parties with obligations thereunder, (b) Yucaipa Manager is an intended beneficiary of all
representations, warranties and covenants contained herein to the extent that they pertain to the
Real Estate Fund Formation Agreement or the REF Warrants and or the REF Underlying Shares and may
enforce such provisions and seek indemnification for any breaches thereof pursuant to the
corresponding provisions of ARTICLE 6 against the Company directly, and (c) Yucaipa
American Funds, LLC is an intended beneficiary of Sections 2.2.1(e) and 5.2(b) and
may enforce such provisions and seek indemnification for any breaches thereof pursuant to the
corresponding provisions of ARTICLE 6 against the Company directly.

 

41

 

7.4 Notices. All notices or other communications required or permitted to be given hereunder
shall be in writing and shall be delivered by hand or sent by a nationally recognized overnight
courier service (with tracking capability), and shall be deemed given when received, as follows:

if to an Investor, to such Investor:

c/o Yucaipa American Alliance Fund II, LLC

9130 W. Sunset Boulevard

Los Angeles, California 90069

Attention: Robert P. Bermingham

with a copy (which shall not constitute notice) to:

Munger, Tolles & Olson LLP

355 South Grand Avenue

35th Floor

Los Angeles, California 90071

Attention: Judith T. Kitano

Fax: (213) 683-4052

Email: judith.kitano@mto.com

if to the Company, to:

475 Tenth Avenue

New York, New York 10018

Attention: David Smail

with a copy (which shall not constitute notice) to:

Sullivan & Cromwell LLP

125 Broad Street

New York, New York 10004

Attention: Robert W. Downes

Fax: (212) 558-3588

Email: downesr@sullcrom.com

With respect to any notice or other deliveries required under the Certificates of Designations
or the Warrants to holders of the Preferred Securities or Warrants, each such notice or other
delivery will, with respect to an Investor or any of its Affiliates, be validly given thereunder
only if such notice or other delivery is delivered by hand or sent by a nationally recognized
overnight courier service (with tracking capability) to the Investors in accordance with this
Section 7.4.

7.5 Counterparts. This Agreement may be executed in one or more counterparts, all of which
shall be considered one and the same agreement, and shall become effective when one or more such
counterparts have been signed by each of the parties hereto and delivered to the other parties
hereto.

 

42

 

7.6 Entire Agreement. This Agreement and the Ancillary Agreements, along with the Schedules
and the Exhibits hereto and thereto, contain the entire agreement and understanding among the
parties hereto with respect to the subject matter hereof and thereof and supersede all prior
agreements and understandings relating to such subject matter. None of the parties shall be liable
or bound to any other party in any manner by any representations, warranties or covenants relating
to such subject matter except as specifically set forth herein or in the Ancillary Agreements.

7.7 Interpretation; Exhibits and Schedules. The headings contained in this Agreement, in any
Exhibit or Schedule hereto and in the table of contents to this Agreement are for reference
purposes only and shall not affect in any way the meaning or interpretation of this Agreement. All
Exhibits and Schedules annexed hereto or referred to herein are hereby incorporated in and made a
part of this Agreement as if set forth in full herein. Any capitalized terms used in any Schedule
or Exhibit but not otherwise defined therein shall have the meaning assigned to such term in this
Agreement. When a reference is made in this Agreement to a Section, Exhibit or Schedule, such
reference shall be to a Section of, or an Exhibit or Schedule to, this Agreement unless otherwise
indicated.

7.8 Severability. If any provision of this Agreement (or any portion thereof) or the
application of any such provision (or any portion thereof) to any person or circumstance shall be
held invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, such
invalidity, illegality or unenforceability shall not affect any other provision hereof (or the
remaining portion thereof) or the application of such provision to any other persons or
circumstances.

7.9 Consent to Jurisdiction. All actions and proceedings arising out of or relating to this
Agreement and the Ancillary Agreements shall be heard and determined exclusively in any New York
state or federal court sitting in the Borough of Manhattan of The City of New York. The parties
hereto hereby (a) submit to the exclusive jurisdiction of any state or federal court sitting in the
Borough of Manhattan of The City of New York for the purpose of any Action arising out of or
relating to this Agreement or the Ancillary Agreements brought by any party hereto, and (b)
irrevocably waive, and agree not to assert by way of motion, defense, or otherwise, in any such
Action, any claim that it is not subject personally to the jurisdiction of the above-named courts,
that its property is exempt or immune from attachment or execution, that the action or proceeding
is brought in an inconvenient forum, that the venue of the Action is improper, or that this
Agreement or the Ancillary Agreements or the transactions contemplated by this Agreement or the
Ancillary Agreements may not be enforced in or by any of the above-named courts.

7.10 Governing Law. This Agreement shall be governed by and construed in accordance with the
laws of the State of New York.

7.11 Waiver of Jury Trial. Each party hereby waives, to the fullest extent permitted by
Applicable Law, any right it may have to a trial by jury in respect to any litigation directly or
indirectly arising out of, under or in connection with this Agreement, any Ancillary Agreement or
any transaction contemplated hereby or thereby. Each party (a) certifies that no representative,
agent or attorney of any other party has represented,

 

43

 

expressly or otherwise, that such other party would not, in the event of litigation, seek to
enforce the foregoing waiver and (b) acknowledges that it and the other parties hereto have been
induced to enter into this Agreement and the Ancillary Agreements, as applicable, by, among other
things, the mutual waivers and certifications in this Section 7.11.

7.12 No Personal Liability of Partners, Directors, Officers, Owners, Etc. No director,
officer, employee, incorporator, stockholder, managing member, member, general partner, limited
partner, principal or other agent of any of the Investors shall have any liability for any
obligations of the Investors under this Agreement or for any claim based on, in respect of, or by
reason of, the obligations of the Investors hereunder. The Company waives and releases all such
liability. This waiver and release is a material inducement to the Investors’ entry into this
Agreement. No director, officer, employee, incorporator, stockholder, managing member, member,
general partner, limited partner, principal or other agent of the Company shall have any liability
for any obligations of the Company under this Agreement or for any claim based on, in respect of,
or by reason of, the obligations of the Company hereunder. The Investors jointly and severally
waive and release all such liability. This waiver and release is a material inducement to the
Company’s entry into this Agreement.

7.13 Rights of Holders. Each party to this Agreement shall have the absolute right to
exercise or refrain from exercising any right or rights that such party may have by reason of this
Agreement, including the right to consent to the waiver or modification of any obligation under
this Agreement, and such party shall not incur any liability to any other party or other holder of
any securities of the Company as a result of exercising or refraining from exercising any such
right or rights.

7.14 Adjustment in Share Numbers and Prices. In the event of any (i) stock split, (ii)
subdivision, (iii) dividend or distribution payable in shares of Common Stock (or other securities
or rights convertible into or entitling the holder thereof to receive directly or indirectly shares
of Common Stock), (iv) combination or (v) other similar recapitalization or event, in each case,
occurring after the date hereof, each reference in this Agreement and the Ancillary Agreements to a
number of shares or a price per share shall be amended to appropriately account for such event.

7.15 Construction. The parties acknowledge that each party and its counsel have participated
in the negotiation and preparation of this Agreement. This Agreement shall be construed without
regard to any presumption or other rule requiring construction against the party causing the
Agreement to be drafted. Every covenant, term and provision of this Agreement shall be construed
simply according to its fair meaning and not strictly for or against any party hereto.

[Signature page follows.]

 

44

 

In Witness Whereof, the Company and the Investors have executed this Agreement as of
the date first above written.

	 	 	 	 	 	 	 
	COMPANY:  
	 
	 	 	 	 	 	 
	MORGANS HOTEL GROUP CO.
	 
	 	 	 	 	 	 
	By:
	 	/s/ Marc Gordon 	 	 
	 	 	 	 	 
	 

	 	Name:	 	Marc Gordon 	 	 
	 

	 	 	 	 	 	 
	 

	 	Title:	 	President 	 	 
	 

	 	 	 	 	 	 

[Investor signatures on following page.]

(Securities Purchase Agreement)

 

 

	 	 	 	 	 	 	 
	INVESTORS:  
	 
	 	 	 	 	 	 
	YUCAIPA AMERICAN ALLIANCE FUND II, L.P.
	 
	 	 	 	 	 	 
	By:	 	Yucaipa American Alliance Fund II, LLC	 	 
	Its:	 	General Partner	 	 
	 
	 	 	 	 	 	 
	By:	 	/s/ Robert P. Bermingham 	 	 
	 	 	 	 	 
	 

	 	Name:
	 	Robert P. Bermingham	 	 
	 

	 	Title:
	 	Vice President	 	 
	 
	 	 	 	 	 	 
	YUCAIPA AMERICAN ALLIANCE (PARALLEL) FUND II, L.P.
	 
	 	 	 	 	 	 
	By:	 	Yucaipa American Alliance Fund II, LLC	 	 
	Its:	 	General Partner	 	 
	 
	 	 	 	 	 	 
	By:	 	/s/ Robert P. Bermingham 	 	 
	 	 	 	 	 
	 

	 	Name:
	 	Robert P. Bermingham	 	 
	 

	 	Title:
	 	Vice President	 	 

(Securities Purchase Agreement)Exhibit 10.2

Exhibit 10.2

Execution Copy

REAL ESTATE FUND FORMATION AGREEMENT

This Real Estate Fund Formation Agreement (this “Agreement”), dated as of
October 15, 2009, is entered into by and between Yucaipa American Alliance Fund II, LLC, a Delaware
limited liability company (“Yucaipa”), and Morgans Hotel Group Co., a Delaware corporation
(“MHG”). In consideration of the promises and representations, warranties, covenants and
agreements contained herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties
hereto hereby agree as follows:

1. The Fund. Yucaipa and MHG shall use good faith efforts to endeavor to raise a
private investment fund (the “Fund”) in accordance
with subparagraphs (a) through
(g) of this Section 1:

(a) The purpose of the Fund will be to, subject to reasonable exceptions to be mutually
agreed by Yucaipa and MHG, invest in (i) hotel real estate projects located in North
America (including, without limitation, (x) the acquisition, development or
redevelopment of hotel real estate projects and (y) investments in, or acquisitions,
development or redevelopment of, condominiums, bars, restaurants, retail establishments,
entertainment venues and other business ventures located within or reasonably related to any
hotel real estate project described in the foregoing clause (y)) directly or
indirectly undertaken by MHG or any of its subsidiaries where there is the opportunity to
own at least a 20% equity interest in such project and to make an equity investment of at
least $10,000,000 (each such project, a “Qualified Morgans Project”) (each
underlying hotel of a Qualified Morgans Project in which the Fund invests, a “Fund
Morgans Hotel”) and (ii) such other hotel real estate projects that are related
to first class full-service hotels as determined by the General Partner; provided
that no hotel real estate project located in North America that had been undertaken by a
person without the participation of MHG or any of its subsidiaries shall be deemed to be a
Qualified Morgans Project if (A) such project is subsequently acquired by MHG or any
of its subsidiaries in connection with the acquisition by MHG or such subsidiary of such
project together with (I) assets other than hotel real estate projects or
(II) hotel real estate projects that are located outside of North America and
(B) a majority of the value of the assets being acquired in such acquisition (as
measured based on allocable purchase price at the time of such acquisition) arises from the
portion of such assets that are either (I) assets other than hotel real estate
projects or (II) hotel real estate projects that are located outside of North
America.

(b) The Fund will have the first right to fund up to the entire equity investment (but
excluding any portion reserved for co-investment by MHG pursuant to the last sentence of
this Section 1(b)) in (i) each Qualified Morgans Project and (ii) other
hotel real estate projects to be mutually agreed by Yucaipa and MHG (such right, the
“Investment Rights”). MHG will not, and will cause its subsidiaries and the
Non-Yucaipa Key Professionals (as defined below) to not, invest in, or cause to be offered
to any person, the opportunity to invest or otherwise participate in any project (including,
without limitation, any Qualified Morgans Project) that is subject to the Investment

 

 

 

Rights, in each case, except to the extent the Fund has been offered in accordance with this
Agreement, and the Fund has declined, such opportunity. The Fund will be deemed to have
declined an opportunity if the Fund does not accept such opportunity within 30 calendar days
after being offered such opportunity in accordance with this Agreement. The General Partner
shall use its reasonable best efforts to complete, and MHG shall use its reasonable best
efforts to provide promptly to the General Partner such information as the General Partner
may reasonably request in order to facilitate the completion of, the General Partner’s due
diligence review of such opportunity within such 30-calendar-day period. If the Fund has
been offered such opportunity in accordance with this Agreement, and the Fund has declined
any portion of such opportunity, then MHG, its affiliates and the Non-Yucaipa Key
Professionals may invest or otherwise participate in such portion on its own or with one or
more third parties; provided that such investment or participation must be on terms
and conditions no more favorable, taken as a whole, to any such participating party in any
material respect than the terms and conditions that were offered to, and declined by, the
Fund, unless (x) such more favorable terms and conditions are offered to the Fund in
accordance with this Agreement and (y) the Fund does not elect, within seven
calendar days after such offer, to invest in such opportunity upon such more favorable terms
and conditions. If the Fund invests in any Qualified Morgans Project, MHG may, in MHG’s
sole discretion, elect to co-invest with the Fund, on a pari passu basis with the Fund and
upon terms and conditions no more favorable to MHG than the terms and conditions applicable
to the Fund’s investment in such Qualified Morgans Project, in such amount as MHG shall
determine up to 20% of the aggregate equity investment of the Fund and MHG in such Qualified
Morgans Project.

(c) The Investment Rights will commence as of the closing of the Fund at which
aggregate capital commitments to the Fund equal or exceed $100,000,000 and will terminate
upon the earliest to occur of (i) the expiration of the Fund’s commitment period,
(ii) the date on which the Fund has invested or committed to invest at least 85% of
the aggregate capital commitments to the Fund, and (iii) the fifth anniversary of
the date hereof.

(d) The aggregate capital commitments of the General Partner (as defined below) and its
affiliates to the Fund (the “GP Commitment”) will be equal to 5% of the aggregate
capital commitments to the Fund; provided that in no event will the GP Commitment be
required to exceed $25,000,000.

(e) The targeted size of the Fund will be between $250,000,000 and $500,000,000 in
aggregate capital commitments to the Fund.

(f) The Fund will be subject to governance and investor rights satisfactory to Yucaipa
and MHG. The Fund will be entitled to consent rights over certain actions of MHG with
respect to Fund Morgans Hotels and each other Fund hotel owned by the Fund that is managed
by MHG or a subsidiary of MHG. The material terms and
conditions of each Fund Morgans Hotel and each other Fund hotel owned by the Fund that
is managed by MHG or a subsidiary of MHG, including, without limitation, the acquisition and
the corresponding renovation/development scope and budget, will be mutually decided by the
Fund and MHG. Furthermore, if MHG or any of its subsidiaries

 

 - 2 - 

 

co-invests in a Qualified
Morgans Project, major decisions of the applicable joint venture established with respect to
the underlying Fund Morgans Hotel will be mutually decided upon by the Fund and MHG. Such
major decisions will include, without limitation, capital expenditures in excess of
applicable reserves or budgets, financings, dispositions and approvals of operating and
capital budgets.

(g) Except as contemplated by this Agreement (including, without limitation,
subparagraphs (a) through (g) of this
Section 1) or otherwise mutually
agreed by Yucaipa and MHG, the terms and conditions of the Fund, and the rights and
obligations of investors in the Fund, will be commercially reasonable, as determined by
reference to prevailing investor expectations, industry standards and market practices for
private investment funds with similar investment objectives as the Fund.

2. The General Partner. The Fund, if successfully organized, shall be controlled by a
general partner (or other equivalent control entity in the case the Fund is not organized as a
limited partnership) (the “General Partner”), which shall be organized as a joint venture
between Yucaipa, its affiliates and its related persons, on the one hand, and MHG, its subsidiaries
and its related persons, on the other hand, in accordance with
subparagraphs (a) through
(d) of this Section 2:

(a) 50% of the equity interests in the General Partner will be allocated to Yucaipa,
its affiliates and its investment professionals in such proportions as Yucaipa may
determine. The remaining 50% of the equity interests in the General Partner will be
allocated to key non-Yucaipa professionals who are (i) employed by, or serve as
directors to, MHG, (ii) actively involved with the Fund, and (iii)
reasonably satisfactory to Yucaipa (such non-Yucaipa professionals, the “Non-Yucaipa Key
Professionals”).

(b) In the event the General Partner issues equity interests to persons other than
Yucaipa, MHG, Non-Yucaipa Key Professionals or their respective subsidiaries, affiliates and
related persons, including, without limitation, in connection with the raising of additional
capital or as allocations to other management and professionals, the equityholders of the
General Partner will be subject to pro rata dilution of their equity interests in the
General Partner.

(c) Yucaipa will assist the Non-Yucaipa Key Professionals in funding their pro rata
share of the GP Commitment by making to them, or causing one of Yucaipa’s affiliates to make
to them, an interest-bearing loan on mutually agreeable terms and conditions to be
determined by Yucaipa and such Non-Yucaipa Key Professionals and secured only by a first
priority lien in favor of Yucaipa or such affiliate, as applicable, on such Non-Yucaipa Key
Professionals’ interests in the General Partner and the Fund. Such loans will be structured
such that Yucaipa or such affiliate, as applicable, will be repaid in full (including,
without limitation, all outstanding principal, accrued and unpaid interest and other amounts
owing under such loans) on a first priority basis before any
distributions are made with respect to the General Partner or the Fund to the
Non-Yucaipa Key Professionals. Such loans shall be made in compliance with the
Sarbanes-Oxley Act.

 

 - 3 - 

 

(d) Except as contemplated by this Agreement (including, without limitation,
subparagraphs (a) through (d) of this Section 2), the terms and
conditions of the General Partner, and the respective rights and obligations of the members
and other owners of equity interests in the General Partner, shall be as mutually agreed by
Yucaipa and MHG in good faith.

3. Fund Hotels. If the Fund is successfully organized, then MHG, whether directly,
through its wholly owned subsidiary Morgans Hotel Group Management LLC or through one or more other
wholly owned subsidiaries of MHG, shall have the first right, except to the extent declined by MHG
and subject to a reasonable transition period in the case such hotel was managed by a third party
at the time the Fund invested in such hotel, to (x) serve as the manager of each hotel
owned by the Fund (regardless of whether such hotel is a Fund Morgans Hotel) and provide expertise
in the operation, direction and supervision of such hotel, and (y) require such hotel to
use MHG’s global technology platforms, reservations systems and global marketing programs. Such
management and use shall be pursuant to a management agreement (each, a “Management
Agreement”) between such hotel and MHG, which shall contain such terms and conditions as are
then generally offered by MHG, at the time such Management Agreement is negotiated and executed, to
unaffiliated third parties under comparable management agreements in the locality where such hotel
is situated and shall otherwise be in a form generally consistent with MHG’s then standard
management agreement with unaffiliated third parties (collectively, the “Morgans Standard
Terms”). The Morgans Standard Terms (subject to local variation) are generally as set forth in
the letter from MHG to Yucaipa, dated the date hereof and referencing
this Section 3. MHG
and the Fund shall in good faith agree to modifications to the Morgans Standard Terms from time to
time as may be reasonably necessary to reflect changes in the marketplace for the hotel management
services or practices of MHG and its affiliates.

4. Conflicts of Interest. In organizing the Fund, Yucaipa and MHG shall use their
reasonable efforts to structure the Fund to minimize the risk of any conflicts of interests. In
addition, the governing documents of the Fund and the General Partner (collectively, including,
without limitation, the limited partnership agreement or other equivalent or related governing
agreements of the Fund and the operating agreement or other equivalent or related governing
agreements of the General Partner, the “Fund Agreements”) shall contain reasonable
conflicts of interest protections, including, without limitation, a requirement that Yucaipa shall
have sole control over the Fund and the General Partner with respect to any decision or action in
which MHG or any of its affiliates has a material pecuniary interest or other conflict of interest.
If Yucaipa determines that there is a decision or action with respect to which MHG or any of its
affiliates has a material pecuniary interest or other conflict of interest sufficient for Yucaipa
to be entitled under the Fund Agreements to exercise sole control over the Fund and the General
Partner with respect to such decision or action, Yucaipa shall inform the Non-Yucaipa Key
Professionals of such determination prior to exercising such sole control over such decision or
action.

5. Issuance of REF Warrants. Concurrently with the execution and delivery of this
Agreement, MHG hereby issues, sells and delivers in certificated form to Yucaipa, and Yucaipa
hereby receives from MHG:

 

 - 4 - 

 

(a) a warrant in the form annexed hereto as Exhibit A to acquire 2,500,000
shares of MHG common stock, par value $0.01 per share (“Common Stock”), subject to
the terms and conditions set forth therein; and

(b) a warrant in the form annexed hereto as Exhibit B to acquire an additional
2,500,000 shares of Common Stock, subject to the terms and conditions set forth therein.

6. Alternative Structures. If Yucaipa and MHG jointly determine that an alternative
form of pooled investment vehicle, another type of financing vehicle or another type of financing
arrangement (each, an “Alternative Structure”), including, without limitation, (a)
any publicly traded special purpose acquisition company, (b) any separate investment
account, or (c) any contractual co-investment relationship, should be formed, arranged or
used in addition or in lieu of the Fund for purposes of undertaking in whole or in part the purpose
or functions of the Fund, then the Yucaipa and MHG shall interpret this Agreement to apply mutatis
mutandis to such Alternative Structure and otherwise effectuate the intent of this Agreement to the
fullest extent reasonably practicable as if references hereunder to the “Fund” also refer to such
Alternative Structure and references hereunder to the capital commitments to the Fund also refer to
the capital of such Alternative Structure; provided that a contractual co-investment
relationship shall only be used in addition to the Fund or another Alternative Structure and shall
invest on a pro rata basis with the Fund or such other Alternative Structure.

7. Termination. This Agreement and the rights and obligations of the parties hereto
hereunder shall terminate automatically on January 30, 2011 if on or prior thereto the Fund has not
closed on at least $100,000,000 in aggregate capital commitments.

8. Amendments and Waivers. This Agreement may not be amended except by an instrument
in writing signed on behalf of each of the parties hereto. Except as otherwise provided in this
Agreement, any failure of any party to comply with any obligation, covenant, agreement or condition
herein may be waived by the party entitled to the benefits thereof only by a written instrument
signed by the party granting such waiver, but such waiver shall not operate as a waiver of, or
estoppel with respect to, any subsequent or other failure. The failure of any party hereto to
assert any of its rights under this Agreement or otherwise shall not constitute a waiver of such
rights.

9. Assignment. This Agreement and the rights and obligations hereunder shall not be
assignable or transferable by any party hereto without the prior written consent of the other party
hereto. Any attempted assignment in violation of this
Section 9 shall be void.

10. No Third-Party Beneficiaries. This Agreement is for the sole benefit of the
parties hereto and their permitted assigns, and nothing herein expressed or implied shall give or
be construed to give to any person, other than the parties hereto and such permitted assigns, any
legal or equitable rights hereunder.

11. Notices. All notices or other communications required or permitted to be given
hereunder shall be in writing and shall be delivered by hand or sent by a nationally recognized
overnight courier service (with tracking capability), and shall be deemed given when received, as
follows:

 

 - 5 - 

 

(a) if to Yucaipa, then to:

Yucaipa American Alliance Fund II, LLC

9130 W. Sunset Boulevard

Los Angeles, California 90069

Attention:       Robert P. Bermingham

with a copy (which shall not constitute notice) to:

Munger, Tolles & Olson LLP

355 South Grand Avenue, 35th Floor

Los Angeles, California 90071

Attention:       Judith T. Kitano

Fax:                (213) 683-4052

Email:             judith.kitano@mto.com

(b) if to MHG, then to:

Morgans Hotel Group Co.

475 Tenth Avenue

New York, New York 10018

Attention:       David Smail

with a copy (which shall not constitute notice) to:

Sullivan & Cromwell LLP

125 Broad Street

New York, New York 10004

Attention:       Robert W. Downes

Fax:
               (212) 558-3588

Email:            downesr@sullcrom.com

12. Counterparts. This Agreement may be executed in one or more counterparts, all of
which shall be considered one and the same agreement, and shall become effective when one or more
such counterparts have been signed by each party hereto and delivered to the other party hereto.

13. Entire Agreement. This Agreement, including the exhibits hereto, contains the
entire agreement and understanding among the parties hereto with respect to the subject matter
hereof and supersedes all prior agreements and understandings relating to such subject matter.
None of the parties hereto shall be liable or bound to any other party in any manner by any
representations, warranties or covenants relating to such subject matter, except (a) as
specifically set forth herein or, (b) in the case of MHG, as set forth in (i) the
Securities
Purchase Agreement, dated as of the hereof, by and among MHG, Yucaipa American Alliance Fund
II, L.P. and Yucaipa American Alliance (Parallel) Fund II, L.P. (the “Securities Purchase
Agreement”), or (ii) the Ancillary Agreements (as defined in the Securities Purchase
Agreement).

 

 - 6 - 

 

14. Interpretation; Exhibits. The headings contained in this Agreement and in any
exhibit hereto are for reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement. All exhibits annexed hereto or referred to herein are hereby
incorporated in and made a part of this Agreement as if set forth in full herein. Any capitalized
terms used in any exhibit but not otherwise defined therein shall have the meaning assigned to such
term in this Agreement. When a reference is made in this Agreement to a “Section” or “Exhibit”,
such reference shall be to a section of, or an exhibit to, this Agreement unless otherwise
indicated. For purposes of this Agreement, (a) an “affiliate” of any person means
another person that, directly or indirectly, through one or more intermediaries, controls, is
controlled by, or is under common control with, such first person, and (b) for purposes of
the foregoing clause (a), a person shall be deemed to control another person if such first
person possesses, directly or indirectly, the power to direct, or cause the direction of, the
management and policies of such other person, whether through the ownership of voting securities,
by contract or otherwise; provided that the existence of a management contract by a person
or an affiliate of such person to manage another person shall not be deemed to be control by such
person; provided further that neither MHG nor any of its subsidiaries shall be
deemed hereunder to be an affiliate of Yucaipa. For purposes of this Agreement, “person”
means any individual, firm, corporation, partnership, limited liability company, trust, joint
venture, governmental entity or other entity.

15. Severability. If any provision of this Agreement (or any portion thereof) or the
application of any such provision (or any portion thereof) to any person or circumstance shall be
held invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, such
invalidity, illegality or unenforceability shall not affect any other provision hereof (or the
remaining portion thereof) or the application of such provision to any other person or
circumstances.

16. Consent to Jurisdiction. All actions and proceedings arising out of or relating
to this Agreement shall be heard and determined exclusively in any New York state or federal court
sitting in the Borough of Manhattan of The City of New York. The parties hereto hereby (a)
submit to the exclusive jurisdiction of any state or federal court sitting in the Borough of
Manhattan of The City of New York for the purpose of any action or proceeding arising out of or
relating to this Agreement brought by any party hereto, and (b) irrevocably waive, and
agree not to assert by way of motion, defense, or otherwise, in any such action or proceeding, any
claim that it is not subject personally to the jurisdiction of the above-named courts, that its
property is exempt or immune from attachment or execution, that the action or proceeding is brought
in an inconvenient forum, that the venue of such action or proceeding is improper, or that this
Agreement or the transactions contemplated by this Agreement may not be enforced in or by any of
the above-named courts.

17. Governing Law. This Agreement shall be governed by and construed in accordance
with the laws of the State of New York.

18. Waiver of Jury Trial. Each party hereto hereby waives, to the fullest extent
permitted by applicable law, any right it may have to a trial by jury in respect to any litigation
directly or indirectly arising out of, under or in connection with this Agreement or any
transaction contemplated hereby. Each party hereto (a) certifies that no representative,
agent or

 

 - 7 - 

 

attorney of any other party has represented, expressly or otherwise, that such other party
would not, in the event of litigation, seek to enforce the foregoing waiver and (b)
acknowledges that it and the other party hereto have been induced to enter into this Agreement by,
among other things, the mutual waivers and certifications in this
Section 18.

19. No Personal Liability of Partners, Directors, Officers, Owners, Etc.

(a) No director, officer, employee, incorporator, stockholder, managing member, member,
general partner, limited partner, principal or other agent of Yucaipa, or any affiliate of
Yucaipa, or any director, officer, employee, incorporator, stockholder, managing member,
member, general partner, limited partner, principal or other agent of such affiliate, shall
have any liability for any obligations of Yucaipa under this Agreement or for any claim
based on, in respect of, or by reason of, the obligations of Yucaipa hereunder. MHG hereby
waives and releases all such liability. This waiver and release is a material inducement to
Yucaipa’s entry into this Agreement.

(b) No director, officer, employee, incorporator, stockholder, managing member, member,
general partner, limited partner, principal or other agent of MHG, or any affiliate of MHG,
or any director, officer, employee, incorporator, stockholder, managing member, member,
general partner, limited partner, principal or other agent of such affiliate, shall have any
liability for any obligations of MHG under this Agreement or for any claim based on, in
respect of, or by reason of, the obligations of MHG hereunder. Yucaipa hereby waives and
releases all such liability. This waiver and release is a material inducement to MHG’s
entry into this Agreement.

20. Rights of Holders. Each party hereto shall have the absolute right to exercise or
refrain from exercising any right or rights that such party may have by reason of this Agreement,
including, without limitation, the right to consent to the waiver or modification of any obligation
under this Agreement, and such party shall not incur any liability to any other party or other
holder of any securities of MHG as a result of exercising or refraining from exercising any such
right or rights.

21. Construction. The parties hereto acknowledge that each such party and its counsel
have participated in the negotiation and preparation of this Agreement. This Agreement shall be
construed without regard to any presumption or other rule requiring construction against the party
causing this Agreement to be drafted. Every covenant, term and provision of this Agreement shall
be construed according to its fair meaning and not strictly for or against any party hereto.

[Signature page follows.]

 

 - 8 - 

 

In witness whereof, Yucaipa and MHG have executed and delivered this Agreement as of
the date first above written.

	 	 	 	 	 
	 	YUCAIPA

Yucaipa American Alliance Fund II, LLC

 	 
	 	By:  	/s/
Robert P. Bermingham 	 
	 	 	Name:  	Robert P. Bermingham 	 
	 	 	Title:  	Vice President 	 
	 
	 	MHG

Morgans Hotel Group Co.

 	 
	 	By:  	/s/
Marc Gordon 	 
	 	 	Name:  	Marc Gordon 	 
	 	 	Title:  	President 	 

 

 

 

	 	 	 	 	 

Exhibit A

Form
of Warrant Issuable under Section 5(a) 

[See Attachment.]

 

 

 

Exhibit B

Form
of Warrant Issuable under Section 5(b)

[See Attachment.]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00164-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00164-of-00352.parquet"}]]